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Abstract
The transparency of the human cornea is vital in maintaining vision. The cells on the
surface, corneal epithelium cells, are constantly replaced by differentiated limbal stem
cells. Damage to the limbus can cause a deficiency in the limbal stem cell population
which can cause cornea opacity and vascularisation consequently leading to blindness.
Currently limbal stem cell deficiency can be detected clinically and treated surgically
by transplanting stem cells onto the damaged cornea. However, the long term success
rate is low 68% and the results vary from patient to patient. There is an interest
to understand the cause for this variability in results and the low long term success
rates.
The aim of the project was to develop an Ultrahigh resolution OCT (UHROCT)
to locate the transplanted corneal epithelium cells. Optical Coherence Tomography
system (OCT) is a non-invasive micron resolution imaging technique that can image
several millimetres in tissue. The cells to be transplanted are labelled with super
paramagnetic iron oxide (SPIO) nanoparticles. After uptake these SPIO embedded
cells are displaced with an external magnetic field at a known frequency whilst being
imaged by the UHROCT. This technique known as phased resolved magnetomotive
OCT, allowed us to locate the oscillating nanoparticle which is embedded in the cell
by detecting the location of the modulation frequency. For the Ultrahigh resolution
OCT a super luminescent diode (SLD) light with centre wavelength at 890× 10−9m
and a bandwidth of 150× 10−9m. The system has an axial and lateral resolution of
2.5µm and 6.20 µm in air respectively. The system was able to detect as low as 1273
SPIO loaded cells/ mm2 on rabbit cornea.
The spectral domain UHROCT constructed was also used to image 3D oral mucosa
constructs. The system shows superior contrast in comparison to 1310 nm swept
source systems. The UHROCT was able to identify key difference between the normal,
dysplastic and malignant construct. For the malignant construct Cal27s, hematoxylin
and eosin staining was used to confirm the formation of a keratinized superficial layer.
The keratinized layer was presented as a hyper-reflective thickened layer superficial to
a darker region on both OCT platforms. This keratinized layer causes a sharp fall in
the signal in the UHROCT making it difficult to visualise the underlying structures
of the construct.
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Chapter 1
Theory and Literature review
1.1 Corneal Physiology
The transparent cornea serves as an entrance for us to capture light from our external
environment. A combination of the avascular nature and the arrangement of collagen
fibre in the stroma make the cornea transparent [1]. It is usually stated that the cornea
provides two thirds of the focussing power of the eye. After the cornea the light travels
through the lens which then focuses it onto the retina. Until recently the cornea was
thought to consist of five basic layers, namely the Epithelium, Bowmans layer, Stroma,
Descements membrane and the Endothelium as shown in figure 1.1.
Figure 1.1: The five traditional cornea layers
However, a new pre-Descement layer has been discovered and is been term the Dua
layer [2]. The first layer the corneal epithelium forms a mechanical barrier and acts
1
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as a bio-defense layer against foreign matter. The layer has been reported to have
a thickness of between 50-52 µm [3].The thickness has been measured more recently
to be 53.4± 4.6 µm in a normal population using a high frequency ultrasound [4].
The thickness of the central cornea and the epithelium layer have been measured
using Optical Coherence Tomography (OCT) as 54.7 ± 1.9 µm and 44.9 ± 3.4 µm
respectively. [5] [6] [7]. The cornea does most of the refracting of light in the eye, light
entering the eye passes through air with refractive index of 1 and enters the cornea
with a refractive index of 1.376. This change in refractive index is the largest the
beam of light experiences on it’s journey onto the retina.
In a healthy individual the cornea is transparent due to the absence of blood vessels.
This attribute of the cornea is very important if the cornea is to refract light effectively
through the lens which then focuses the light onto the retina. The vascularisation
of the cornea changes its refractive index and hence its refracting properties and
may lead to ocular conditions. An interesting question arises about how the corneal
epithelium cells are kept functioning without any blood supply. The corneal cells
source of nutrients is the tear film. The tear film, consisting of water mucin and
lipids, the tear film allows oxygen to be transported through it to the corneal cells.
It flushes away foreign products and protects against shear forces generated when
blinking and during eye movements. Waste products are channeled away in the tear
film from the cornea into the tear ducts to be drained. It is generally accepted that
corneal epithelium is regenerative and the regenerative action is centripetal. New
epithelial cells move from the peripheral to the centre of the cornea, this movement
have been observed in corneal epithelial wound healing experiments conducted by
both Buck and Kuwabara [8] [9]. Kuwabara describes this centripetal movement as a
sliding of the epithelium cells fuelled by the cells’ glycogen storage. Even though there
is a general agreement about the trajectory of new epithelium cells there are however
two main hypothesis about the origin of these replacement corneal epithelium cells.
2
1.1. CORNEAL PHYSIOLOGY
1.1.1 Limbal Stem Cell Transportation
1.1.1.1 Limbal Stem Cells
The prevailing hypothesis is that the regeneration of the corneal epithelium cells is
dependent on the availability and activity of primitive stem cells, the limbal epithe-
lium stem cells. The limbal region encompasses the cornea and separates the cornea
and conjunctiva. The Limbal region is highly vascular and was thought to be the site
for limbal stem cells until H.S. Dua confirmed the existence of limbal stem cell niches
now termed the lImbus or palisades of Vogt [10]. Due to the shape of the palisade of
Vogt and its folding structure it provides protection against mechanical stresses and
damages [11]. It is also thought that within the palisade of Vogt the stem cells can
remain in their undifferentiated state [12]. Limbal stem cells are thought to initially
differentiate to form transient amplifying cells (TAC), these TAC reside on the basal
layer of the corneal epithelium. The TACs have a higher differentiation rate than the
stem cells but have a limited proliferation capacity. Once produced the TAC migrate
towards the surface of the epithelium whilst differentiating to form terminal cells to
replenish the superficial corneal epithelium cells as illustrated in figure 1.2 [13]. A
complete replacement cycle occurs every 5 to 7 days [14].
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Figure 1.2: Limbal Epithelium Stem Cell Transportation [13]
The stem cell hypothesis is based on experimental observations. Two of these obser-
vations are that the limbal basal epithelium contains the lowest differentiated cells in
the cornea epithelium and the cells in the basal layer of the limbal niches exhibit the
proliferative behaviours of stem cells.
The basal layer epithelium has the least differentiated cells
The different cell populations in the cornea epithelium was only segmented after
varying levels of keratin expressions were observed. The presence of some keratins
are evidence of high level of differentiation while others are mainly found in less dif-
ferentiated cells. The use of antibodies allowed the identification of 64 kDa keratin
K3, this keratin and its pair K12 indicates cornea specific type of differentiation. The
presence of the 64 kDa keratin K3 in the suprabasal epithelium of the limbus and
its absence in the basal layer or the conjunctiva led to the hypothesis that the lim-
bus basal epithelium cells had not differentiated to have cornea phenotype and hence
would be the least differentiated cells of the epithelium [15]. Further investigations
have revealed that the basal limbal epithelium shows no expression of the keratin
K12, however, this keratin is expressed throughout the cornea epithelium. These
4
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observations led to the conclusion that the basal limbal epithelium is the least differ-
entiated region in the entire cornea epithelium. Further evidence supporting the stem
cell hypothesis includes the absence of keratin K19 in the supra basal layers and the
cornea epithelium. Keratin K19 is linked with low differentiation phenotype. Since
keratin K19 is, however, observed in the adult limbal basal epithelium and in a foetus
throughout the entire cornea epithelium and the limbus; it may therefore mean that
the basal limbal layer contains embroyogenetically young cells (stem cells). Cells in
the peripherals have been identified to contain expressions of K19 this could be due
to the centripetal cell migration [16].
The limbal basal cells exhibit proliferative behaviours similar to stem
cells
Cells can be labelled with agents which identify their rate of mitotic division, this
technique has been used to differentiate between fast and slow proliferating cells.
Short term labelling experiments can be conducted to identify fast cycling cells such as
epithelium cells and transient amplifying cells. However, longer labelling experiments
are needed to identify stem cells which innately have slow cycles. Using labelling
experiments Cotsarelis and his group were one of the first to be able to distinguish
between stem cells and transient amplifying cells in the basal layer of the limbus [17].
The group initially experimented for a short period, in their experimentation they
labelled cells with tritiated thymidine and noticed cell proliferation in both the limbal
and peripheral corneal basal epithelium. This was used as identification of the TAC
cells, the group then extended the period of application of the tritiated thymidine to
14 days and observation period to 4 weeks. With these conditions only a few cells in
the limbal basal epithelium layer showed any proliferations. The team concluded that
the cycling time of the limbal stem cells was no longer than 2 weeks. The phenotype
of these cells in the basal layer are primitive as they stay round and small. This was
confirmed using in vivo confocal microscopy [18].
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1.1.1.2 Conjunctival Transdifferentiation
The second hypothesis originated when conjunctival epithelium ingrowth was found
on denuded cornea during a cornea wound healing experiment. Some patients af-
ter damaging their cornea and limbus would develop a seemingly normal cornea.
Experiments showed that in the absence of blood supply the conjunctival epithe-
lium cells on the corneal surface loses its conjunctival phenotype and becomes more
cornea-like [19]. This observation led to idea that in a healthy individual the corneal
epithelium is maintained by the neighbouring conjunctival epithelium. However, his-
tological analysis has shown that the phenotype of these transdifferentiated conjunc-
tival epithelium (TDCE) differs from that of true cornea epithelium. An example
of this is the absence of goblet cells on the cornea when the limbus is completely
damaged whilst normally goblet cells are present on the cornea producing mucin and
antibacterial proteins for the protection of the cornea [20] [21]. Another interest-
ing observation is that the transdifferentiation can be inhibited by the presence of
vascularisation. This gave birth to the idea that there must be a component in the
blood supply which is needed to maintain the conjunctival phenotype. This idea was
pursued by Tseng who identified retonic acid to be one of the possibly many compo-
nents in the blood which inhibits the transddifferentiation process [22]. Retonic acid
is also needed for the differentiation of goblet cells. For these reasons and more it
has been shown that transdifferentiated cornea epithelium is inherently different from
genuine corneal epithelium. Additional studies shows that transdifferentiation does
not happen, at least in animal models. It may be due to the subtotal loss of limbal
epithelium stem cells and early transient amplifying cells. The incomplete loss of the
limbus may allow the reconstruction of the cornea after a certain period when the the
limbal epithelium has been restored. This process may be mistaken as conjunctival
transdifferentiation.
6
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1.2 Limbal Stem Cell Deficiency (LSCD)
The limbal region has two important role, firstly to keep the cornea healthy by replac-
ing the epithelium cells and secondly to act as a mechanical barrier separating the
avascular corneal cells from the vascularised conjunctival cells [23]. Damage to the
limbal region will compromise the region’s ability to complete these functions. Severe
damages can lead to a painful disease known as limbal stem cell deficiency (LSCD)
where the limbal stem cells population is severely reduced. For a LSCD sufferer the
transparent cornea is no longer maintained but it is invaded by the neighbouring
conjunctiva cells. The vascular conjunctiva begins to form blood vessel connection
over the cornea. LSCD can lead to severe vision impairment and even blindness.
There are numerous reasons for the onset of the disease. Reasons include hereditary
conditions such as Aniridia [24], chemical/thermal burns, inflammatory diseases and
even improper use of contact lens which may inflame the limbus [25]. LSCD is clini-
cally diagnosed usually by the scarring and vascularisation of the corneal epithelium.
The diagnosis can be confirmed with a corneal impression cytology test [26] [27].
This technique simply checks for the presence of conjunctival cells on a filter paper
placed over the corneal epithelium. A high count of conjunctival epithelium cells
could indicate limbal stem cell deficiency.
1.2.1 Treatments
Depending on the extent of the damage and whether the damage is bilateral (both
eyes) or unilateral (single eye), a limbal allograft or limbal autograft can be done. For
a LSCD patient with unilateral damage, the usual treatment would be an autograft.
In a limbal autograft, stem cells are taken from the undamaged eye and harvested for
transplantation onto the damaged eye. This is only possible if the damage is unilateral
or if both eyes are affected then a small area of the limbus must be healthy. Whiles
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auto grafting is the preferred treatment it is not always applicable e.g. if the damage is
bilateral. In this situation an allograft is the second choice with this the stem cells are
sourced from a relative. The undamaged stem cells are transplanted into the damage
limbus after any conjunctival or scarring tissues are removed [28] [29]. Due to the high
vascularisation of the limbus patients who undergo allograft transplantation will have
to take immunosuppressants forever or until the transplant become viable [30]. For the
cells to be transplanted a carrier is needed. A carrier is used to transport the healthy
cells onto the patient’s cornea. It dissintigrates over time leaving the transported
donor corneal cells on the patient’s cornea. The usual carrier tends to be Human
Amniotic Membrane (HAM). The amniotic membrane is a good carrier because it
has antimicrobial, antiviral, anti-inflammatory and inhibits fibrosis [31] [32]. Other
reasons for the use of HAM are because of its low immunogenicity [33] [34] and its
previous roles in healing corneal after thermal and chemical burns [35]. More recently
cell expansion techniques have been developed. These techniques allow for smaller
amounts of stem cells to be removed from donor cell, which is then cultured and
expanded. The donor stem cells are obtained by anaesthetising the eye and gently
scraping the limbal region. This technique avoids the case where limbal stem cell
deficiency is induced in the donor eye [36]. With this technique the small amount
of stem cells proliferates in the laboratory until a large enough mass is acquired.
The benefits of this technique is that there is a small chance of inducing LSCD in
the donor eye and it is possible to attempt a second biopsy of the donor if the first
treatment was not successful. The donor cells are transferred to the recipient eye
either via fibrin[30], inactivated 3T3 mouse fibroblasts or human amniotic membrane
[37] [38] [39]. New biodegradable synthetic carriers are being developed to replace
the amniotic membrane which has to be stored in banks. A biodegradable carrier has
been synthesised out of poly-lactide-co-glycolide(PLGA) using a 50:50 ratio of lactide
and glycolide [40]. PLGA shows good prospects due to its low cytotoxicity and that
fact that it is already used in ocular surgeries.
Initially limbal damage was treated by full corneal transplant however these were not
very successful. The low success rate was due to the fact that there usually aren’t
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enough stem cells in the recipient eye to sustain the regeneration process. [40] [41].
Now the preferred treatment, aims to replace, or increase, the population of limbal
stem cells specifically. This can be done either by autologous or allografting. Limbal
grafting techniques via human amniotic membrane have a fairly high success rate
(76%) in the short term (a year or less) but the success rates fall as time passes.
After 4 years the rate of success will have fallen to 68.2% [42]. So any reoccurring
symptoms would mean that the treatment was unsuccessful. It has also been shown
that the success rate increases after the second transplantation and also grafts that
were considered successful after the first year remained successful [43].
The aim of the research is to be able to identify the transplanted limbal epithelium
cells using Optical Coherence Tomography and possibly find some reasoning for this
high failure rate in the long term. This would be a great step towards increasing the
long term success rate of the transplantation surgeries.
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1.3 Principle of Optical Coherence Tomography
Optical Coherence tomography is a non invasive imaging technique which generates
two dimensional and three dimensional tomograms of materials using low temporally
coherent light sources. The technique was developed from the principle of low co-
herence interferometry (LCI) [44]. The application of LCI for biological tissues was
first explored by D. Huang in 1991 [45] [46]. OCT uses the principle of coherence
gating to measure the temporal source of constructive interferences and uses this to
produces images unlike conventional microscopy which uses spatial gating. OCT can
be based on different types of interferometers such as Mirau [47], Fizeau [48], Mach-
Zehnder and the Michelson interferometer. Haungs original system was based on the
Michelson interferometer (see figure 1.3).
Figure 1.3: Michelson Interferometer
Most systems’ set-up are based on the Michelson interferometer configuration, the
system we used in our investigations was also based on this configuration. Hence we
will be discussing the Michelson configuration type system. In the set-up, the light
beam emitted from the source is incident onto a beam splitter or coupler which splits
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the source beam into two output beams with their individual intensities dependent
on the splitting ratio of the coupler or splitter. One of the beams travels towards
the sample and the other towards a plane mirror, these are respectively described as
the sample and reference arms. The plane mirror serves as a length reference. The
reflected and scattered beams from the different layers in the sample are recombined
by the splitter/coupler with the beam reflected by the reference mirror. The returning
beams are also split according to the coupling/splitting ratio of the splitter. As an
example a 50/50 split coupler will be recombining at most 25% of the source power
from each arm. The emerging beam is then directed onto the detector. Due to
the low coherence of the light source, constructive interference only occurs on the
detector when the optical path of the reference and sample arms is matched within
the coherence length of the source. [49].
The proportion of return light received by the detector can be very low in systems but
this can be improved in fibre based systems by using favourable couplers such a 70/30
split ratio for ophthalmic imaging where there is a power restriction sample incident
light. A single sample depth profile known as an A scan (axial scan) is acquired in the
direction of the reference mirror scan. In Fourier domain systems there is no scanning
and an A scan is acquired by either sweeping through the wavelength range of the
light source and hence probing different depths in swept source systems or by using
a diffraction grating to dispersing the recombined beam into individual wavelength
components in spectral domain systems. The probing sample beam can be scanned
in one direction (laterally, perpendicular to the axial) to produce a B scan or in two
directions to produce a three dimension image.
11
1.3. PRINCIPLE OF OPTICAL COHERENCE TOMOGRAPHY
The interference recorded for a single reflector by the detector is of the form
E(ω, τ) = s(ω)exp
[i(ωτ+kz)] (1.1)
Ein(ω, τ) = s(ω)e
iωτ (1.2)
Er(ω, τ,∆z) = (TrTs)
1/2Ein(ω, τ)e
iφ(∆z) (1.3)
Es(ω, τ) = (TrTs)
1/2Ein(ω, τ)H(ω) (1.4)
Eout(ω, τ,∆z) = Er(ω, τ) + Es(ω, τ,∆z) (1.5)
where φ the phase difference between the sample beam and reference
φ(∆z) =
2ωnair∆z
c
(1.6)
Integrating over time gives the intensity, the angular brackets are used to denote the
time average
I(ω,∆z) = 〈Eout(ω, τ,∆z)Eout(ω, τ,∆z)〉 (1.7)
I(ω,∆z) = 〈EsEs∗〉+ 〈ErEr∗〉+ 2IREsEr∗ (1.8)
I(τ) = Is + Ir + 2I0
√
TrTs|γ(τ)| cos(ωτ + φ) (1.9)
Equation (1.1) describes a plane polarized wave, with amplitude s(ω), frequency ω
and time variation τ . Wavenumber k and distance z explain the phase throughout
the interferometer. Ein, Eout, Er and Es, are the optical fields in the input, output,
reference and sample arms, respectively
I(τ) is the intensity recorded by the detector, I0 is the source intensity, Ir and Is are
the intensity due to the self-interference in the reference and sample arm respectively.
Tr and Ts are the transmission coefficients. The sum of Ir and Is gives the DC
component of the signal. The third term give the cross interference. γ is the partial
coherence term. ω and τ are the frequency of oscillation and the time delay between
the beam from the reference and the sample arm. The cosine term carries the depth
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information.
The image quality depends on several parameters, the most important is the sensi-
tivity or signal to noise ratio SNR; the SNR determines the brightness of the images.
Sensitivity is discussed in more detail in section 1.3.1. The other major parameters
are the lateral and axial resolution.
Lateral Resolution
The lateral resolution is dependent on the imaging optics, using a sample lens with a
high numerical aperture will produce a small spot size improving the lateral resolution.
For example, if we direct a Gaussian beam centred at λ through a lens with focal
length f and fill the aperture d, a 2ω spot size is created where this is equivalent
to the lateral resolution ∆x of the OCT system, ω is half the beam diameter at the
waist.
∆x =
4 · λ · f
pi · d (1.10)
Equation (2.18) calculates the theoretical lateral resolution using the system’s op-
tics parameters. However, in practical applications resolution test targets are used
to measure lateral resolution. A common one is the USAF resolution target plates
as shown below in figure 1.4. The target plates have groups of lines with the num-
ber of lines per millimetre known. The lateral resolution of the system is therefore
taken as the smallest line pair the system can distinguish, according to the Rayleigh
criterion.
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Figure 1.4: USAF resolution target [50]
Although using a high numerical aperture is desirable for an improved lateral resolu-
tion, it decreases the imaging depth. In our investigations where we are predominately
interested in a superficial layer, the epithelium we can improve the lateral resolution
at the expense of the imaging depth.
Axial Resolution
The axial resolution ∆z is defined as half the coherence length of the light source.
For a light beam with a Gaussian spectral profile, the coherence length lc is related
to the centre wavelength of the source λo and the bandwidth ∆λ as measured at the
full width half maximum (FWHM).
lc =
4ln2
npi
λ2
∆λ
(1.11)
∆z =
lc
2
(1.12)
In practical measurements the axial resolution is measured by measuring the FWHM
of the point spread function PSF. The PSF is calculated by Fourier transforming the
interference recorded by the detector. In this measurement a plane mirror is used as
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the sample for it’s high reflectivity and low scattering properties.
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(a) Interference signal on top of the spectrum prior to reference sub-
traction been done
(b) The PSF near zero optical path difference/OPD
(c) The arrows showing where the axial resolution would be measured
FWHM (-3dB)
Figure 1.5: The y axis is recording intensity in decibels and the x axis shows the
number of pixels. These were recorded using a linescan CCD(EV71YEM1GE2014-
BA9)
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1.3.1 Sensitivity
The most common measurement of sensitivity is the signal to noise ratio (SNR). With
SNR the recombined signal power is normalised by dividing it by the noise floor.
This is convenient because it allows images to be compared even after brightness and
contrast modifications.
The spectral domain set up used in our investigations provides an improvement in
the SNR. Sensitivity in time domain is lower than that in the spectral domain by
a factor of (N/2) where N is the number of pixels. The derivation is demonstrated
below.
SensitivityTDOCT = 10 log
4 · Psig · t · 
h · ν
2
N
(1.13)
Psig =
∫
Ssample dω (1.14)
SensitivitySDOCT = 10 log
4Psig · t · 
h · ν (1.15)
SensitivityTDOCT = SensitivitySDOCT − 10 log N
2
(1.16)
where N = number of pixels, Psig is the power returned from the sample arm, t is
the acquisition time,  is the quantum efficiency of the detector and hν is the photon
energy These formulas are derived in [51]. However, a more mathematically detailed
description can be found by Leitgebs group [52].
1.3.1.1 Sensitivity Roll off
In our study sensitivity roll off is defined as how much the sensitivity fall with depth
measured as dB/mm. With the aim of achieving high axial resolution in spectral
domain OCT a broadband light source is used. The return light going onto the
detector is dispersed into smaller wavelength ’packets’ and each wavelength must
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be detected to utilise the full power of the light source. The spectrometers used,
however, have a fixed and limited number of pixels on the detector and hence has to
bin wavelengths together. This has an averaging effect on the spectral waveform [51].
In Swept Source OCT (SSOCT) the light source outputs single frequencies per unit
time, which is then detected by a photo-diode so this averaging effect is reduced, so
the rate of sensitivity fall in SSOCT is much less than in SDOCT. Another reason why
the sensitivity decreases with depth is because the finite resolution of the spectrometer
reduces fringe visibility more significantly at high frequencies [53]. The rate at which
sensitivity falls has been described below. The sinc function in equation (1.17) is from
the Fourier transformation of the rectangular pixels and is multiplied by the Gaussian
beam profile. The roll-off rate, R(z), after the Fourier transform of the interference
signal is given as the product of a sinc function and the Gaussian function as shown
below:
R(z) =
(
sin ξ
ξ
)2
exp
[− w2
2ln2
ξ
]
(1.17)
where
ξ =
(pi
2
)( z
zmax
)
zmax =
λ2
4∆λ
w =
δλ
∆λ
where zmax is the maximum imaging depth, ∆δ is the spectral resolution and ∆λ is
the wavelength pixel spacing as proved by [51]. Figure 1.6 shows the theoretical SNR
roll off for our OCT system with zmax=2.1 mm, λ=890× 10−9m, ∆λ=150× 10−9m
and w =1.58. A SNR roll off of 12.3 dB/mm is predicted.
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Figure 1.6: Sensitivity roll off calculated using system parameters
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1.4 Magnetomotive OCT
In the project we propose to use magnetomotive OCT (MMOCT) to track the labelled
limbal epithelium cells. In magnetomotive OCT we induce a shift or displacement
in the spatial domain by the use of a magnetic field gradient. The sample under
investigation is labelled with magnetic nanoparticles which can be functionalised with
various groups. The magnetic particles used in the experiments are described in
section 3.2. These particles are then actuated by the external magnetic field, usually
the resultant displacement caused is too minute (order of nanometres) to be detected
via structural OCT imaging, however phase resolved OCT can detect the resultant
change in phase due to these displacement. The actuation of the nanoparticles causes
small displacement changes in the cells’ locations. Commonly the magnetic field
gradient is usually generated by a solenoid. The solenoid can be constructed with an
air core or with a metal with a high magnetic permeability such as iron or mild steel.
Constructing the solenoid with a ferrite core increases the magnetic field strength but
it concentrates the field around the core. Inserting a core allows the use of a lower
current to achieve a desired magnetic field strength.
The labelled cells experience the greatest forces in the axial direction due to the
orientation of the magnetic field lines, this is ideal for OCT since usually the axial
resolution is higher than the lateral. MMOCTs can detect change in displacement
either via amplitude modulation or phase modulation. In amplitude modulation a
B scan is acquired with the magnetic field on and actuating the nanoparticles, this
image is then compared to that of the same sample location but with the magnetic
field off. A subtraction of the two images will lead to zero values at all the pixels in the
image apart from the location of the nanoparticles because during the two images the
location of the nanoparticles will be different [54]. Due to the need of imaging twice
the technique is time expensive, it is possible to utilise phase modulation detection.
In this scheme the nanoparticles are modulated at a set frequency, the image is then
acquired and either a short time Fourier transform or wavelet transforms can be
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applied to detect the location of that particular frequency [55].
1.4.1 Phase Stability
In phase resolved technique the phase stability of the OCT system is important as it
sets the limit on the lowest phase change the system can detect. Phase stability is
described as the standard deviation of the phase fluctuations usually of a plane mirror,
since a plane mirror doesn’t usually exhibit any phase fluctuations, any fluctuations
detected can be attributed to the instabilities in the system.
Theoretically it can be calculated as below:
δφ =
√
1
SNR
(1.18)
[56] where SNR = 10(SNR(dB)/10)
For a given measured phase difference ∆φ, we can obtain the physical displacement
using equation (1.22).
∆φ = 2nω∆t (1.19)
∆φ =
2npic
λo
∆z
c
(1.20)
∆φ =
4npi
λo
∆z (1.21)
∆z =
∆φλo
4npi
(1.22)
where ∆z is the change in displacement, λo is the centre wavelength and n is the
refractive index, ω is the angular frequency.
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Chapter 2
Ultra High Resolution Spectral
Domain OCT (UHR-SDOCT) for
corneal imaging
2.1 Summary
In this chapter, we discuss optical coherence tomography, the theory and how the
system used in our study was constructed. Properties such as axial and lateral res-
olution along with sensitivity and depth roll off are also discussed. The methods for
measuring the properties are also discussed. The measured parameters are compared
to the theoretically calculated values.
2.2 Introduction
This chapter discusses the construction of the Ultrahigh Resolution Spectral Domain
Optical Coherence Tomography system (UHRSDOCT) which throughout the thesis
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will be referred to as OCT system and the Magnetomotive OCT (MMOCT). The
UHRSDOCT was used for imaging oral mucosal tissue, rabbit cornea and then ex-
tended and adapted to perform as a Magnetomotive OCT (MMOCT). The MMOCT
was used to locate labelled cells while the UHR-SDOCT was used to produce high
resolution images of the corneal epithelium to help with the visualisation of the lim-
bus. For these requirements the system needs not only high resolution but also good
phase stability to allow the locating and tracking of the labelled stem cells using the
MMOCT.
The system is fibre based and built on a Michelson interferometer configuration.
A 50/50 fibre coupler is used to split the source beam and also to recombine the
scattered and reflected beams from the reference and sample arm. Most components
of the system are caged to increase the phase stability which is essential for making
accurate displacement measurements. The whole system was then placed on vibration
absorbing rubber.
Spectral domain OCT systems require no reference arm scanning for it’s image for-
mation, this reduces the image acquisition time. Spectral Domain OCT (SDOCT)
has an increased efficiency due to the use of a spectrometer to detect the interference
signal in the detector arm [1]. The spectrometer increases the sensitivity of the sys-
tem. A sensitivity increase of 21.7dB compared to the time domain OCT has been
published [2] [3]. In the spectral domain OCT, the detected spectral interference is
recorded in terms of wavelength to allow for the retrieval of sample depth informa-
tion, the spectral interference data is re-sampled into evenly spaced wave numbers
and Fourier transformed into the spatial domain to retrieve the depth information of
the sample.
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2.3 Experimental Setup
2.3.1 Light Source
In building an ultra-high resolution OCT system the choice of light source is critical.
A common choice is the Super-Luminescent diode (SLDs). These can be fabricated
to produce a variety of spectra with different combinations of central wavelengths and
bandwidths whilst giving a usable output power (>3mW). A dual SLD (Broadlighter
D890-HP, Superlumdiodes Ltd) with centre wavelength λo = 890 nm and a bandwidth
∆λ = 150 nm was used. Figure 2.1 shows the spectrum of the light source recorded
using an optical spectrum analyser. The source emits partially polarized light with a
nominal power of 4.9 mW. The theoretical axial resolution of the system is determined
by the central wavelength and bandwidth of the light source.
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Figure 2.1: Spectrum of Light Source measured using Spectrum Analyser with both
SLDs on. The presence of the ripples are due to internal reflection in the SLD
An optical isolator (OFR IO-SLD150-895 APC) was used to reduce the power of
light reflected from the interferometer set-up back into the source. The trade off
31
2.3. EXPERIMENTAL SETUP
for this safety feature is the reduction in the power of the light beam entering the
interferometer. A reduction of source power by 0.1 dB was measured.
Figure 2.2 is a schematic drawing of the Ultrahigh resolution OCT system and a
photograph is attached in the appendix.
Figure 2.2: Spectral Domain OCT Experimental Set-up
2.3.2 Optical Fibre and Coupler
The system is fibre based, the fibre used throughout most of the system was Nufern
630-HP.The single mode fibre has a core diameter of 3.5µm, a core numerical aperture
of 0.130 and a cladding diameter of 125.0±1.0µm. A 2×2 fibre coupler (Gould Optics)
with a 50/50 splitting ratio and a 3 dB insertion ratio was used to split the source
beam into the reference and sample beams figure 2.2.
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2.3.3 Sample arm component
The sample to be imaged is placed at the end of the sample arm. During alignment
and calibration, a plane mirror is used as a sample due to it’s high reflectivity. There-
fore, a higher proportion of the light is reflected into the detector. The galvanometer
system(Thorlabs, GVS002) allows for the lateral scanning of the sample to provide
B scans (2D images). The galvanometer system has a pair of galvanometer scanners
(TSH 22556-Y and TSH 22555-X) and this allows the system to acquire volumetric
images. The scanners are powered via a National Instrument DAQ board which is
controlled using a bespoke LabView software. A telecentric scanning lens (Thorlabs,
LSM02-BB) with an effective focal length of 17.93 mm, ×10magnification and spot
size of 9 µm (these values are quoted for beam with centre wavelength of 850 nm)
giving a numerical aperture of 0.11.
Initially the sample plate (holds the sample or plane mirror during alignment) had
2 thumbscrews for adjustment however this gave low amounts of returned light to
the detector. The two screw adjustment plate was changed for a plate with three
adjustment screws. A 3% increase in the sample arm return power is achieved with
the three point adjustable screws. Optimising the sample arm return power(Ps) is of
great importance because the maximization of this power will improve the SNR of
the system.
SNR = 10log
4Pst
hν
(2.1)
Equation (2.1) as stated in [3] defines the shot noise limited signal to noise ratio
(SNR) or the optical dynamic range in terms of Ps the fractional power reflected
by the sample arm, t the exposure (signal collection time),  the detector quantum
efficiency and hν the photon energy.
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2.3.4 Reference arm components
In the reference arm the light beam emitted from the coupler is reflected by a plane
mirror. A dispersion compensator (Thorlabs, LSM02DC) was placed in the path of
the beam after the collimator so that the beam travels through the same length of
material, in this case glass, in both the reference and the sample arm. The dispersion
compensator has an identical refractive index and thickness as the focusing lens in
the sample arm. Without the compensator the axial resolution degrades due to
extra chromatic dispersion experience by the sample beam relative to the reference
beam. Also a variable neutral density filter was needed to attenuate the signal from
the reference arm, without this attenuation the reference signal (0.28 mW) would
saturate the CCD.
2.3.5 Detector arm components
Light from the sample and reference arms are recombined by the coupler and travels
into the detector arm. The detector arm is composed of an in house built spectrom-
eter. The light emitted from the coupler fibre tip passes through a collimating lens.
This serves as a beam expander to increase the illumination spot size on the diffrac-
tion grating. The diffraction grating of the spectrometer was changed from reflective
to a transmission grating with 820 lp/mm to a transmission grating (Wasatch Pho-
tonics) with 1200 lp/mm. The increased lp/mm increases the angle of dispersion and
hence from a fixed distance away the transmission grating model would disperse the
spectrum across larger number of the CCD pixels and therefore give a better spectral
resolution. The improved spectral resolution will increase the imaging depth [4] [5].
The CCD camera used in the experimentations that follows is the Aviiva EV71YEM1GE2014-
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BA9. It is a line scan camera with 2048 rectangular pixels with dimension 14µm ×
28µm. The photon counts and exposure time has a linear relationship as seen in fig-
ure 2.3. This is expected because the longer the CCD spends collecting photons the
higher the photon count will be. However, for the gain the photon counts increases in
steps. With light incident on the CCD pixels, there is no change in intensity recorded
by changing the gain, the gain has to be increase from the lowest -24dB to -21dB
before an increase in number of intensity is seen and then increased to a gain of -15
dB to see another increase. The count dependency on gain is not linear figure 2.4.
The gain setting changes the conversion ratio in the pre amplifier before the signal
enters the analogue to digital converter (ADC). A higher gain gives a higher output
voltage for the fixed photon flux on the CCD pixels. Therefore, a lower photon flux
is needed to saturate the output of the ADC.
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Figure 2.3: Photon counts increases
with exposure time
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Figure 2.4: Photon counts showing in-
crement in steps for increasing gain
The optimal gain setting was found to be -12 dB for the shortest exposure time of 50
µs. Increasing the gain above -12 dB increases the noise by the same amount as the
signal so there is no overall benefit. From equation (2.1) we see that by increasing the
exposure time increases the SNR but this increases the time needed to acquire the
image. With the project being aimed for clinical implementation the lowest exposure
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time was used. Even with the lower exposure time the SNR achieved (95 dB) is
comparable to the systems of some of the leading groups in the field.
There is a maximum power limit before the CCD saturates. The CCD saturation
level is dependent on its full well capacity; the maximum number of electrons each
pixel can hold. Any excess electrons may be leaked into neighbouring pixels causing
saturation.
The optical power required to saturate the CCD charge wells can be calculated from
the manufacturer’s data as follows.
Full well capacity per pixel = 312500 electrons (2.2)
Full well capacity for array = 312500× 2048 (2.3)
= 640× 106 electrons (2.4)
Full well energy = Full well capacity× h× f (2.5)
Full well energy (Saturation Energy) = (2.6)
(640× 106)× 6.63× 10−34 ×
(
3× 108
890× 10−9
)
(2.7)
= 1.43× 10−10J
Saturation Power =
Saturation Energy
Exposure time
(2.8)
=
(
1.43× 10−10
50× 10−6
)
(2.9)
= 2.86µW
Saturation power per pixel = 2.86µW/2048 (2.10)
= 1.40nW (2.11)
(2.12)
If the power falling onto the CCD is larger than 2.86 µW then we get saturation. The
ADC output could also be saturated depending on the Gain.
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2.3.6 Spectrometer components
Equation (2.13) gives the angular dispersion (δθ) of a beam passing through a grating.
For our set-up the diffraction order (m) is 1. To increase the angular dispersion, the
line spacing(d) must be decreased. So the 1200 lp/mm will have a larger angular
dispersion and hence the spectrum will cover a larger number of pixels improving the
spectral resolution.
Angular dispersion :
δθ
δλ
=
m
dcosθ
(2.13)
The smallest separation between two wavelengths which the grating can resolve is
known as the resolving power
ResolvingPower = mN =
λ
δλ
(2.14)
where m is the order of diffraction which is 1 for our system, d is the separation
between adjacent slits (inverse of number of grooves) and N= total number of grooves
illuminated on grating.
The collimated beam entering the detector arm has a diameter of 5 mm. This beam
is incident on the diffraction grating. Using the transmission grating gives a resolving
power of 6000 using equation (2.14). The transmission grating (1200 lp/mm) gives
a central spectral resolution of 890 nm/6000=0.15nm.The resolution will be slightly
better at the lower wavelength 815 nm (0.14 nm) and slightly higher resolution at the
higher wavelength 965 nm (0.16 nm).
The diffracted beam exiting the grating needs to be focused onto the CCD pixels.
The lenses in the spectrometer focuses the diffracted spectrum from the grating onto
the CCD pixels. The source has a bandwidth of 150nm this needs to fit onto the 2048
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pixels which has a combined length (l) of 28.67mm (2048 × 14µm). To achieve a
spectral resolution of 0.15 nm and detect the full 150 nm bandwidth, the least number
of pixels needed is 150nm
0.15nm
= 1000 pixels. The CCD used, has twice this amount of
pixels. However, for the FFT and resampling only 1600 pixels are used since the
interference covers only this number of pixels. The light beam is incident on the
diffraction grating at an angle of 35o. This gives a centre wavelength diffraction angle
of −29.63◦. The lowest wavelength (815nm) has diffraction angle of −23.85◦ and
the highest wavelength (965nm) has a diffraction angle of −35.76◦. Therefore, the
spectral range 815-965 nm is dispersed at −29.63± 6.5◦. The angular spread (∆θ) is
13◦.
Figure 2.5: Shows dispersion angle onto the pixel array
The focal length of the optics is given by:
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F =
l
2
÷ tan
(
∆θ
2
)
(2.15)
F =
28.67
2
÷ tan(6.5◦) (2.16)
F = 125.86mm
Initially 3 identical focusing lenses (total focal length =75 mm) were used in the
spectrometer, one followed by the other. Each lens has a focal length of 200 mm.
The number of focusing lens was changed to 2 instead with an effective focal length=
100 mm.
The 2 lenses give a much closer focal length to the calculated equation (2.15) than the
3 lens combination. The excess 25.86 mm from equation (2.15) was achieved by the
use of micrometer stage to move the camera towards the lenses. The larger 100mm
focal plane length allows the spectrum to be dispersed over a larger number of pixels.
The spectrum covering a larger number of pixels will improve the spectral resolution
and the sensitivity roll off with depth. The sensitivity roll off with depth is dependent
on the optical resolution limit of the spectrometer and the pixel width [3].
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2.4 Matching Path Length
To obtain constructive interference between the sample (a mirror during alignment)
and the reference mirror the optical path lengths of both arms must be matched so
the zero path difference occurs conveniently close to the tissue surface. The length
of fibre in each arm is measured taking into account, alongside the refractive index
of the fibre (glass, nglass=1.47) the air gaps. The sensitivity of the detector depends
on the sample return power equation (2.1), so the first the sample mirror is moved
to the focal plane of the sample arm focusing lens for the maximum return power
and then the reference arm mirror is moved to a position to equal the length of the
sample arm. At the point of zero path length difference the point spread function has
the highest amplitude and narrowest width.
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2.5 Imaging Parameters
2.5.1 Axial Resolution
An advantage of OCT is that the axial and lateral resolutions of the system are
independent of each other. The axial resolution is dependent on the source used and
the lateral is defined by the optics. The axial resolution (∆z) is described as half the
coherence length of the source:
∆(z) =
2ln2
npi
λ2
∆λ
(2.17)
Where λ is the central wavelength, ∆λ is the spectral bandwidth of the light source
and n is the refractive index of the sample medium.
The source being used has a theoretical axial resolution of 2.3 µm in air. However
due to the camera’s wavelength dependent responsitivity an axial resolution of 2.5 µm
was achieved. The success of the project is tied to the axial resolution. The higher
the resolution the more probable it is that the corneal cells may be identified and the
corneal layers differentiated.
The axial resolution can be measured from the full width half maximum of the point
spread function(PSF). The PSF is found by Fourier transforming the interference
signal.
When the sample path length is matched to the reference arm path length within the
coherence length of spectral channel we get interference. Figure 2.6a shows the inter-
ference recorded using all 2048 pixels of the CCD camera. However, the interference
does not cover all the pixels but approximately 1600 pixels. So these 1600 pixels were
selected to be used in the re-sampling and Fourier transformation after the reference
power is subtracted Figure 2.6b. The reference power is subtracted by blocking the
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sample arm and recoding the reference power, spectrum is then saved and subtracted
from the interference spectrum.
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Figure 2.6: Stages in measuring axial resolution
For the re-sampling, 1600 pixels were used from pixel 350 to 1950. In figure 2.6b
the reference power has been subtracted so the remaining signal should be a cosine
modulation. The cosine should be centred around zero because usually the reference
power is much greater than the sample arm power. However, in the set-up the sample
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power is similar to the reference power so there is still some DC component on the
interference even after the reference subtraction.
The PSF is obtained by Fourier transforming the interference and taking the squared
modulus. This gives the power spectrum against depth. The axial resolution was
measured to be 2.5±0.3 µm in air, this is lower than the theoretical 2.3 µm. The
difference is most likely due to the chromatic dispersion and the optics not been
perfectly aligned. Figure 2.6c shows the PSF at for mirror position 400 µm from zero
path difference. In Figure 2.6 shows the points used to measure the axial resolution
in green.
After the beam is dispersed onto the CCD, the recorded spectrum is linear in wave-
length but needs to be re-sampled to be linear in wave number. The re-sampled
spectrum is Fourier transformed. Without re-sampling the PSF is very broad and
gives large axial resolutions and also the axial resolution deteriorates rapidly with
depth. The resampling was done using the zero crossing technique. A LabView pro-
gram was written to carry out this process. The LabView script was written by Dr.
Zenghai Lu, based on code supplied with a commercial swept-source OCT system
(EX 1301, Michelson Diagnostics Ltd). This technique works by finding the points
where the cosine modulations cross the zero point. Assuming that these points should
be periodic, it can be used to re-sample the interference signal in wave number.
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2.5.2 Lateral Resolution
The lateral resolution (∆x) is dependent on the geometric parameters of the sample
arm focssing optics.
∆x =
4λf
pid
(2.18)
Where f and d are the focal length and d is spot size of the focusing lens. The lens has
a focal length of 17.95 mm and a spot size diameter of 4 mm so a lateral resolution
of 5 µm is the optimum.
The resolution of each group and element on USAF resolution target was calculated
as follows:
Resolution(lp/mm) = 2(group+((element−1)/6) (2.19)
Resolution(mm) =
1
2× lp/mm (2.20)
The lateral resolution was measured using a resolution targets. The resolution target
(Edmund Optics, 1951 USAF) is a glass plate with chrome patterned lines. The lines
are sectioned into groups and elements. Each group has 6 elements and each element
has 3 lines (no chrome) and 2 lines with chrome. The lines have equal widths. The
widths of the lines decrease with increasing group numbers (-2 to 7), in each group the
width of the lines decreases with increasing element number. The lateral resolution
is defined by the smallest lines resolvable. An en face image figure 2.7 was acquired
of the resolution target and the smallest element which was resolvable was group 6
element 3 which equates to a lateral resolution of 6.20 µm.
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Figure 2.7: Enface image of USAF resolution target taken using the SDOCT. Group
6 element 3 is the smallest resolvable element
A gray scale profile showing the gray scale levels across the whole of group 6 following
the green dashed arrow on figure 2.7. Figure 2.8 is the gray scale profile of group
6. From the profile it is evident that the last resolvable element is 3. Each element
should have two peaks representing the bright regions on the USAF resolution target.
The red dashed line on the profile plot are placed at the beginning of element 2,
the boundary between elements 2/3 and at the end of element 3. The peaks within
element 2 and 3 are resolvable.
The peaks in elements have contrast greater than 50% whilst the higher elements
have contrast levels lower than this.
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Figure 2.8: Gray scale profile plot of enface image of USAF resolution target. Red
dashed lines show boundaries of elements 2 and 3
2.5.3 Sensitivity
The sensitivity is defined as the minimum reflected signal detectable from a sample.
It can also be looked at as the difference between the signal and noise variance. The
sensitivity is normally defined numerically as a decibel ratio of the signal power to
the noise (SNR) power (20log(
Psignal
Pnoise
)). The are three main sources of noise in OCT
systems shot noise, Relative Intensity Noise(RIN) and detector noise. The shot noise
arises from the random arrival of photons in the sample signal. The RIN is produced
by instabilities in the light source and finally the detector noise is due to thermal
fluctuations in the detector, ADC quantization noise etc. Ideally the OCT system
should be shot noise limited.
2.5.3.1 Method
Initially the point of of zero path difference needed to be found and the back reflected
signals in the sample and reference arms need to be maximised. This will increase
the amplitudes of the interferences since the SNR is mainly dependent on the sample
return power equation (2.1). The sample arm is moved into a position where the
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maximum return power is achieved and then the reference mirror moved until the
paths in the arms are equal. In the sample arm a focusing lens is used to focus the
beam onto the sample. Therefore, the mirror (used as a sample) has to be placed
onto the stage and adjusted in the depth direction until the surface of the mirror is at
the focal plane of the focusing lens. Once at the focal plane the angle of the sample
was adjusted using the thumb-screws underneath the sample. These were adjusted to
give a maximum sample return power. This power also saturates the CCD therefore
a pair of neutral density filters with attenuation of 40 dB were used in the sample
arm to reduce the sample return power. At the focus plane the sample return power
is highest. In the reference arm the mirror is adjusted to back reflect the most light
into the coupler. The returned reference arm power exceeded the saturation limit of
the CCD detector, so had to be attenuated with a wheel neutral density filter. The
SNR can also be increased by adjusting the polarisation controls in the sample and
reference arms to place both arms in the same polarisation state to ensure maximum
interference. Once the reference and sample return powers have been maximised the
camera position can be adjusted in the pitch, yaw, x y and z directions to allow all
the diffracted beam to fall onto the camera pixels. Finally, with the beam falling
onto the CCD pixels the interference signal can be used to resample the interference
signal from wavelength to wavevector and then Fourier transformed to give a PSF
with sensitivity of 95 dB.
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2.5.4 Sensitivity roll off with depth
As the path difference changes increases from zero i.e. the depth being probed in-
creases the signal being detected decreases. This decrease of sensitivity is described
as the sensitivity roll off. The sensitivity roll off gives the usable imaging depth, since
if the sensitivity falls too low approximately below 80dB the image appears dark and
difficult to image biological samples.
In OCT, images are produced using coherence interferometry unlike other sub micron
imaging modalities which may use confocal gating. In coherence interferometry, the
maximum signal is detected when the path lengths in the arms of the interferometer
are equal. As the path length difference becomes non zero the signal decreases. If the
path length difference is larger than the coherence length of the light source the signal
falls rapidly. This path length condition means that OCT can reject background
noises which are incoherent. In the confocal gated modalities, the signal strength
and background noise rejection is achieved through the use of lens combinations
and a pin hole. The lens combination used in these modalities for example in the
confocal microscopy means the laser beam is focused on a single sample plane. The
pin hole plane is the conjugate plane of sample plane, so in an ideal situation only
back scattered emissions from this plane will make it though the pin hole and onto the
detector. The diagram below illustrates the working and difference between coherence
and confocal gating.
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Figure 2.9: Difference between confocal and coherence gating
In coherent gating case in figure 2.9 there is only interference if the path length of
the reference arm and the sample is matched and in this case the path is matched
when the sample light is reflected from a point along the solid red line. So from this
point there is interference but there is no interference from signals reflected from the
above dashed line or the dash line below. In the confocal gating case the signal is only
detected if the reflected beam focuses at the pin hole and this only happens when the
sample plane is the conjugate of the pin hole plane. So in this case we only detect
the reflection from the solid red line and not the dashed lines.
2.5.5 Method
To measure the SNR roll off, firstly the interference needs to be re-sampled. We find
that the SNR is greatest at the path difference where the re-sampling lookup table
was generated. The roll off characterises the fall of SNR with depth so the depth
needs to be calibrated. The depth is calibrated by moving the reference arm by a
known distance(1mm) using its micrometer stage and noting how many pixels the
PSF moves. For the SNR roll off data below the system was calibrated as 1mm: 375
pixels. Therefore, every pixel is 2.7 µm. The SNR roll off measurement was started
from 100 µm instead of zero path difference due to the DC component, which is still
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slightly present after subtraction. From 100 µm the sample is moved in increments of
100 µm and the SNR is remeasured. The progression of the SNR roll off is graphed
in figure 2.10.
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Figure 2.10: Sensitivity roll off with depth for 1mm
The SNR roll off was measured to be 6.5 dB/mm (difference between the peak at
1mm and the highest peak before). The SNR roll off appears to be better than the
predicted this is discussed in the following subsection.
The SNR roll off is a very important measurement since it determines our imaging
depth. Our result of 6.5 dB/mm is very comparable to systems with larger number of
CCD pixels [6]. For the project large imaging depths are not crucial but it is desired
because without out this the system will be limited to imaging only low scattering
materials and superficial tissues. Also the axial resolution decreases with increasing
depth. This noticeable with the increasing FWHM of the PSF with depth. The PSFs
at 400 µm has a larger SNR compared to the other even the PSF closer to zero OPD.
This is because the re-sampling from wavelength to k was done at this depth so the
interpolation is more accurate than at higher or lower fringe frequencies.
50
2.5. IMAGING PARAMETERS
2.5.6 Theoretical against measured Performance
The loss in sensitivity with increasing depth is a disadvantage in using SDOCT. The
loss is due to various factors including the limited spectrometer resolution, the finite
width of the pixels and aliasing at high spatial frequencies as described in section
1.3.1.1.
Comparing our measured SNR roll off to that predicted by equation (1.17) our mea-
sured SNR roll off of 6.5 dB/mm is an improvement on the theoretical prediction of
12.3 dB/mm. This occurs because from zero depth to 0.4 mm (3rd peak in figure 2.10)
the SNR increases rather than decrease and then falls after this point. The reason for
this happening is due to the limitations in the resampling algorithm. Normally once
resampling is done regardless at which frequency it was done the SNR is greatest at
zero path difference and decreases there after, because the fringe frequency is lowest
at the zero path difference and is easily resolved. However, this is not the case here,
a possible reason for this could be that a higher order polynomial is needed when re
sampling from wavelength λ to wave vector k. So the conversion is accurate at the
frequency where resampling is done but falls in accuracy as the frequency reduces
(smaller depth) and increases (larger depth). To get a better SNR roll off curve, the
peaks in the SNR data are plot(blue line in figure 2.11) and a Gaussian curve is fitted
(red line in figure 2.11) to the data. The fit curve addresses the problem of the the
SNR increasing with depth. The fit curve has a decreasing SNR with depth. The
fitted curve gives a SNR roll of rate of 8.84 dB/mm this is still better than the shot
noise limit theoretical rate. However, the theoretical rate is calculated based on the
spectral resolution of the spectrometer. The spectral resolution δλ is calculated from
knowing how much of the diffraction grating is illuminated, measuring this value is
tricky and therefore carries with it some error. Calculating the wavelength pixel ∆λ
spacing also carries errors since you can’t exactly sure how much bandwidth you are
collecting on the CCD.
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Figure 2.11: Gaussian curve fitted to sensitivity peaks. The green cross on the plot
were not used in calculating the Gaussian fit curve a × e− (x−b)
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2.6 Magnetomotive OCT
To track the corneal limbal epithelium stem cells, a functional OCT is needed. We
decided to build and use a magnetomotive OCT for this purpose. This adaptation
would require a solenoid for the actuation of the iron nanoparticles. A mild steel core
solenoid was made and placed 1 cm beneath the sample. The mild steel is used to
increase the field strength. The solenoid has a length of 3 cm and with 1200 turns.
The solenoid produces a field of 0.08T at the sample position which was 1 cm away
from the tip of the magnetic core, when a current of 1.6 A is applied at a modulation
frequency of 80 Hz. The solenoid has a field gradient of 7.5 T/m.
Before constructing the solenoid, a magnetic field strength calculation was done to
give an estimate of the parameters needed to achieve a field strength of 0.08 T.
B =
µNI
L
(2.21)
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Equation (2.21) was used to calculate the magnetic field strength of a solenoid. Where
B is the magnetic field strength, µ is the magnetic permeability of the core, N is the
number of turns and L the length of the solenoid.
The magnetic field strength increases proportionally with the wire turn density (N
L
),
however the minimum value of L could not be less than 3 cm due to the design of
the coil winder. The coil winder could not wind a solenoid shorter than 3 cm. The
applied current was to be 1.6 A but could be increased to give higher field strengths,
this increase however would cause the wires wound around the core to start smoking
before the imaging was complete. According to the British Stainless Steel Association
(BSSA), the mild steel used as the core should have a magnetic permeability between
1.3 − 1.4 × 10−6. Using these parameters and a mean permeability of 1.35 × 10−6 a
predicted 1100 turns was needed to achieve our desired field strength of 0.08 T. In
practise 1200 turns was needed as the magnetic permeability was most likely lower
than was used theoretically.
Figure 2.12:
Magnetomotive OCT Experimental Set-up
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2.6.1 Phase stability
The minimum displacement detectable via this technique is limited by the phase
stability of the system. The phase stability for a shot noise limited system is defined
as the standard deviation of the phase fluctuations of a mirror [7] [8].
Phase fluctuation (∆φ) rads =
√
1
SNR
(2.22)
where SNR = 10SNR(dB)/10
The system has a sensitivity of 95 dB this should give a theoretical phase stability of
17.8 µrads using equation (2.22).
The phase fluctuations can be converted into the minimum linear displacement mea-
surable by using:
Displacement (∆z) =
∆φλo
4pin
(2.23)
To measure the phase stability experimentally, a M-mode scan (A scans at a single
point) of a plane mirror is taken as shown in figure 2.13. During a M-mode scan the
galvonometer scanners are held stationary. The depth with the highest reflectivity
is selected for the phase calculation, in this case 0.9 mm. The highest reflectivity
corresponds to the surface. The CCD is set to collect a 1000 A-scans in 50 µs. Taking
the Fourier transforms of these A-scans gives complex expressions and the phase
is obtained by finding the angles between the real and the imaginary components
of these complex expressions. The phase fluctuations with time at the surface is
shown in figure 2.14. The phase stability is measured as the standard deviation
of the phase fluctuation. The dataset recorded had a phase stability of 522 µrad,
using equation (2.23) this converts to a minimum detectable displacement of 0.37
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A˚. The minimum detectable displacement is approximately 30 times larger than the
theoretical prediction of 0.0126A˚ from equation (2.22).
Figure 2.15 shows the Fourier transform of the phase fluctuations, this was done to
show that there are no underlying vibrations without the application of the solenoid.
If there were, prominent peaks at those frequencies would be present. The figure
shows that there is only random noise present.
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Chapter 3
Imaging corneal limbal epithelium
stem cells using Magnetomotive
OCT
3.1 Summary
The prevailing hypothesis for the existence and healing of the avascular corneal epithe-
lium is that this layer of cells is continually produced by stem cells in the limbus and
transported onto the cornea to mature into corneal epithelium. Limbal Stem Cell De-
ficiency (LSCD), in which the stem cell population is depleted, can lead to blindness.
LSCD can be caused by chemical and thermal burns to the eye. A popular treatment,
especially in emerging economies such as India, is the transplantation of limbal stem
cells onto damaged limbus with hope of repopulating the region. Hence regenerat-
ing the corneal epithelium. In order to gain insights into the success rates of this
treatment, new imaging technologies are needed in order to track the transplanted
cells. Optical Coherence Tomography (OCT) is well known for its high resolution
in vivo images of the retina. A custom OCT system has been built to image the
corneal surface, to investigate the fate of transplanted limbal stem cells. We evaluate
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magneto-labelling for tracking the transplanted cells. To evaluate magneto-labelling
the stem cells are loaded with magnetic nanoparticles (20-30nm in size) and then
imaged with a custom-built, magneto-motive OCT system. The imaging was done on
a mixture of SPIO with gelatin, agar and finally on rabbit cornea. The results show
that the system can detect transplanted cells with SPIOs embedded.
3.2 Introduction
Magnetomotive Optical Coherence Tomography is a functional adaptation of OCT.
An electromagnet is used to displace the magnetic contrast agents in a sample and
the displacement is retrieved via phase resolved measurements. The MMOCT can
operate as an amplitude modulator, in this case a scan is taken of the sample with
the magnetic (B) field off (control) and then the scan repeated with the B field
on. The location of the contrast agents are identified by subtracting the images.
This technique is quite slow because it requires scanning the sample twice before
the contrast agents can be located. However, it is possible to modulate the B field
at a set frequency fB and then carry out a lock in detection at this frequency to
locate the contrast agents. In the experiments conducted, superparamagnetic iron
oxides are used. Superparamagnetism is a subset of magnetism which applies to
small ferromagnetic or ferrimagnetic nanoparticles. Small refers to a diameter size of
between 3-50nm. Superparamagnetic materials which essential have a single magnetic
domain can be magnetised by change in temperature but when an external magnetic
field is applied they align with the field applied. The application of an external
field to the superparamagnetic materials causes the material to be displaced. The
displacements experienced by the superparamagnetic iron oxide (SPIOs) causes a
phase change in the interferometric signal recorded.
In OCT the intensity recorded is the sum of self interference from the reference Ir,
sample arms Is and the cross interference 2IR{IrI∗s} . The cross interference carries
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encodes the depth information used in producing the image.
Iout = Ir + Is + 2IR{IrI∗s}
2IR{IrI∗s} = 2cos(kz + φ)
∆φ(∆z) =
2ωnair∆z
c
(3.1)
From equation (3.1), we know that a shift ∆z in the spatial domain will manifest as
a change in the phase.
The purpose of this study was to demonstrate that MMOCT system with superpara-
magnetic iron oxide (SPIO) nanoparticles as contrast agents can be used to locate and
track stem cells on the cornea. Three experiments were carried out the first was M-
mode imaging of gelatine/milk samples mixed with SPIOs, this experiment was done
to test and validate the MMOCT system. Also this was done to investigate whether
the MMOCT could detect SPIOs at a depth and whether the SPIOs surroundings
had an effect on the phase modulation. A M-mode is an acquisition technique, where
the imaging beam is held in a fixed location. M-mode shows the reflectance of region
been imaged evolves with time.
Before the arrival of the rabbit corneas agar phantoms were used as a replacement
for the corneas. Agar phantoms are commonly used to mimic the mechanical and
optical properties of soft tissue [1]. SPIOs were placed both on top of the agar
samples to test whether the SPIO location could be highlighted even in the presence
of strong Fresnel reflection. Finally, rabbit limbal epithelium cells (rLEC) embedded
with SPIOs were transplanted onto the rabbit cornea epithelium. Different rLEC
densities were transplanted onto the cornea and investigated.
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3.3 Materials
3.3.1 Superparamagnetic iron oxide (SPIO) nanoparticles
Magnetite Fe
(II,III)
3 O4 SPIO nanoparticles powder (#637106, Sigma Aldrich) of size
20-30 nm were used [2] . SPIOs in this size range can be used in both in-vivo and
in-vitro applications. In 1996 the FDA approved the use of magnetite SPIOs after
a toxicology study [3]. The particles are uncoated so we do see aggregation of the
particles during preparation and imaging. Different coatings can be used to reduce the
aggregation effect and also the use of coatings such as dextran and aminosilane [4] [5]
have been said to improve the cellular uptake of SPIO in mouse macrophages. Bare
SPIO have been shown not to affect cell viability in various tissues [4]. The particles
are paramagnetic and hence the force exerted on particles remains in one direction
irrespective of the polarity of the magnetic field.
~Fp =
V (χp − χmedium)∇ | ~B |2
2µo
(3.2)
~Fp is the force exerted on particle, χp is the magnetic susceptibility of the SPIO
particle, χmedium is the magnetic susceptibility of the medium surrounding SPIO
particle and ~B is the magnetic field.
3.3.2 Magnetic field generator
We constructed an in-house MMOCT using a wound solenoid with a ferrite core (mild
steel). The solenoid has both length and outer radius of 3 cm and with 1200 wire
turns. The solenoid produces a field of 0.08 T at the sample position ( 1 cm away)
when a current of 1.6 A is applied at a modulation frequency of 80 Hz. The solenoid
61
3.3. MATERIALS
has a field gradient of 7.5 T/m at this frequency.
3.3.3 Animal models
Animal models, eyes were obtained from New Zealand albino rabbits generously do-
nated by Dr. Toby Holmes (University of Sheffield) and also some eyes from wild-bred
rabbits were purchased (Blackface Meat Company). The eyes were removed and dis-
sected to separate the posterior and anterior segments. The reason for dissection is
to allow the cornea to be flattened for imaging, if not flattened due to the cornea’s
curvature the limbus can not be imaged because of the SNR roll off with depth. The
dissection of the eyes does not mean that the MMOCT imaging technique can not be
used in a clinical setting. In a clinical environment the patient can be asked to look
in various directions and to turn their head, so the region of the eye been imaged is
nearly perpendicular to the imaging beam.
3.3.3.1 Rabbit limbal epithelial cells (rLEC)
To replicate the clinical scenario rLEC are harvested from the rabbit’s limbus to later
be labelled with SPIO and transplanted back onto the cornea to be located using the
MMOCT system. Before harvesting the rLEC, the eyes are cleaned initially by remov-
ing excess fat and tissue on the globe and then disinfected using 3% videne antiseptic
solution(Ecolab, Swindon, UK). The limbal region of the cornea was excised into seg-
ments and placed into Dispase II of concentration 2.5 mg/ml(Roche Diagnostics Ltd)
at 37oC and 5% CO2 for 45 min. The limbal cells are then scraped off the tissues into
phosphate buffered saline(PBS) solution using a blunt scalpel blade. The PBS and
limbal cells solution was centrifuged at 1000 rpm for 5 min. The supernatant was dis-
carded and the cells were re-suspended in fresh epithelial culture medium. The cells
were seeded into flasks containing growth arrested NIH3T3 murine fibroblasts as a
feeder layer. The culturing media for the rLEC consisted of Dulbecco’s Modified Ea-
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gle Medium (DMEM GlutaMAXTM, D0819-500ml) and Ham’s F12 medium (N4888-
6x500mL) with 1:1 ratio augmented with 10% foetal calf serum (F9665-500mL), 5
µg/ml insulin(91077C-1G), 10 ng/ml epidermal growth factor(E5036-200UG), 2.5
µg/ml Amphoterin B (A2942-100mL)and 100 U/ml penicillin with 100 g/ml strepto-
mycin (P0781-100mL) the above components are purchased from Sigma Aldrich. For
the experimentation passage 2 cells were used.
The figure 3.1 below shows the experimental setup of the MMOCT system. The
system is the based on the previously built ultra-high resolution SDOCT with the
main addition being the electromagnet.
Figure 3.1: Phase resolved MMOCT experimental setup
where OI: Optical Isolator, PC: polarization controller, LP: linear polarizer, CL: colli-
mating lens, NDF: Neutral density filter, DC: dispersion compensation, FL: focusing
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lens and CCD: charged couple device.
Figure 3.2: Phase resolved MMOCT experimental setup
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3.4 M-mode imaging of gelatine phantoms
The MMOCT system works by actuating the SPIO nanoparticles with an external
magnetic field at a specified frequency. The aims of this experiment was to firstly
determine if the B field produced by the solenoid is sufficient, then to investigate if
the SPIOs actuations could be detected by phase resolving the interferometric data
from the MMOCT and finally confirm the signal detected originated from the SPIOs.
In this experiment phantoms were made compromising of gelatine and milk. The
milk is added as an optical scatterer. M-modes were acquired of the phantoms, to be
used to analyse how the amplitude and phase of the spectral data evolve over time
with the B field being modulated. The phase fluctuations will be used to verify the
magnetic modulation frequency detected corresponds to double the frequency applied
and also used to calculate the displacement of the SPIOs.
3.4.1 Method
The current for the solenoid originates from a function generator (#72-6805,Tenma)
and is amplified by an audio amplifier (#7224, AE Techron) to a peak current of
1.6 A. This current gives a B field strength of 0.08 T. The peak B field produced by
the solenoid was measured using a Gaussmeter (GM05,Hirst). For this experiment a
modulation frequency of 20 Hz was used. The field was measured to be 144.6 mT on
the tip of the solenoid core and 80 mT at the sample position. The B field produced is
comparable to that found in the literature for similar set-up and experimentation [2].
Gelatine phantoms were made using 2.5 mg of dried gelatine with 50 mL of milk to
act as an optical scatterer. Six concentrations 1 mg/ml, 0.5 mg/ml, 0.25 mg/ml,
0.1 mg/ml, 0.05 mg/ml, 0.01 mg/ml and control where no SPIOs are added; 20 µl
of each was pipetted into a petri dish to be imaged. For example, the 0.01 mg/ml
corresponds to a mass of 0.01 mg of SPIO mixed in a 1 ml solution of the gelatine
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and milk solution. A-scans were collected with a camera line rate of 20 kHz and a
camera exposure time of 50 µs. The camera acquisition rate seems quite high for the
modulation frequency applied to the SPIO and hence the modulation frequency is
seen quite close to the DC component. Nevertheless, there is clear evidence for the
presence of magnetic induced displacement. The high exposure time is selected to
collect the maximum signal. The aim of this experiment is not fast acquisition but to
confirm that a magnetically induced signal can be observed. The solenoid is placed
1 cm underneath the sample and the magnetic field is applied whiles the A scans
are acquired. A schematic of the sample set up in relation with the electromagnet
is show in figure 3.2. After the collection of one frame consisting of a 1000 A scans,
the phase was evaluated at a constant depth of 20 µm underneath the surface for the
duration of the acquisition. The MMOCT signal detectable will fall with depth. As
SNR falls so does the MMOCT sensitivity. The depth of 20 µm was used so the area
of investigation is close enough to surface but not at the surface. The MATLAB script
used to process the phase and frequency detection is attached in the Appendix.
A one dimensional Fourier transform of the phase is computed along the transverse
direction to give the frequency components in the phase signal at this depth.
Figure 3.3a shows the M-mode image of the 0.01 mg/ml sample. All the other con-
centrations have very similar structural M-mode images and does not give any extra
information so are not included here. The green line shows the line of interest (20
µm) where the phase resolving technique was applied.
3.4.2 Results
Five SPIO concentrations and a control were investigated. With the magnetic field
applied the SPIOs should be displaced along the axial direction predominately. This is
assumed due to the close proximity of the sample to the tip of the electromagnet. The
M mode acquisitions shows the evolution of the SPIO’s displacement with time. The
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spectrum of the displacements gives a modulation frequency of twice the modulation
frequency (fB) due to the paramagnetic nature of the nanoparticles.
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In figure 3.4a the first peak is at the 40Hz, this is twice the frequency applied (20Hz)
to the samples. This is discussed in the subsequent section.
A control sample (without any SPIOs) was also processed to confirm that without
the SPIOs there should be no magnetic induced displacement signals present. The
amplitude for the 40Hz component is a lot smaller in comparison to the samples
containing SPIOs as seen in figure 3.5b.
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In the higher SPIO concentration samples >1mg/ml the phase modulation is greater
and much more evident graphically. Below is the phase graph for sample with 1mg/ml
of SPIOs to gelatine, it exhibits prominent phase modulation at the 40Hz.
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3.4.3 Discussion
The milk was added to the gelatine to act as an optical scatterer, to increase the
amount of return reflected light. This increases the SNR and thus reduces the phase
noise floor. Although a frequency of 20Hz is applied to SPIOs, a frequency of 40Hz
is detected. The doubling of the applied frequency is due to the paramagnetic nature
of the nanoparticles. Regardless of the direction of the B field the nanoparticles
are attracted to the solenoid. The doubling of the frequency is also explained by
equation (3.2), the squaring of the B field causes the force to oscillate at a second
harmonic of the field oscillation frequency. For the control sample there is no presence
of the magnetically induced signals. The samples containing SPIOs show a frequency
response with an amplitude greater than the controls at 40Hz. The difference in
amplitude ranges from four times greater in the 0.01mg/ml sample to an order of
magnitude for the 1mg/ml sample.
It is possible for the control sample to show a presence of magnetic induced signals.
This occurs if the parts of the MMOCT system in the vicinity of the solenoid can
be magnetised. However, the frequency would be at the fundamental frequency if
the parts gained a permanent remnant magnetization. Taking this into account the
sample holder was constructed of a plastic composite. This can be noticed more easily
in 2D MMOCT imaging where the whole sample would exhibit magnetically induced
displacements because the whole sample is displaced not localised regions within.
The above results show that the samples with SPIOs present do exhibit magnetic
induction motion and can be detected using our MMOCT system. The signal can be
detected in concentrations as low as 0.01mg/ml corresponding to 2.7× 10−22g of iron
within 20µl sample volume.
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3.5 Agar Phantoms
Our overall aim of the project was to detect the location of SPIOs embedded in rLEC
on the cornea. One challenge would be the Fresnel refection at the air-cornea interface.
We used agar to mimic the cornea since agar would also give a high reflectivity at the
surface. Agar is commonly used as tissue mimicking phantom [6]. In this experiment
we investigate the sensitivity of the MMOCT system to SPIOs on an air/agar interface
and also whether SPIOs at a depth can also be detected.
3.5.1 Method
The experimental setup is the same as the one used in the M-mode imaging, however,
here B-scans are acquired so the spatial positions of the SPIOs can be identified. In
this experiment the SPIO nanoparticles are embedded into rabbit limbal epithelium
cells (rLEC), these loaded cells are then transplanted onto the agar surface to be lo-
cated. The rLEC are transported in media, the reflection from the air/liquid interface
causes bright Fresnel reflection. This is due to the large change in refractive index
at the air-liquid interface. To acquire B scans and maintain transverse phase corre-
lation, the acquisition rate of the camera is reduced to oversample in the transverse
direction. The oversample leads to an increase in acquisition time so to compensate
the image length is reduced from 4mm to 2mm.
3.5.1.1 rLEC Preparation
In the experiment 1.5% agar is used. The agar is made from powder agar with PBS.
The agar is allowed to set and then the rabbit limbal epithelium cells (rLEC) were
placed on top. The rLEC has the SPIO embedded. The rLEC were cultured in a
SPIO/media solution of concentration 83µg/ml for 24 hours to allow for the uptake
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of the nanoparticles. After the time had elapsed the rLEC are washed four times with
PBS and the supernatant discarded. This is done to remove any SPIOs not taken up
by the rLEC. The rLEC loaded with SPIOs are obtained by firstly using 3ml trypsin
for approximately 2 minutes to dislocate the cells from the base of the T75 flask in
which they are cultured. The trypsin is the then inhibited by the rLEC media which
contains FCS. The resulting solute is centrifuged at 1000 rpm for 5 minutes. The
supernatant is discarded to leave behind the SPIO embedded cell pellet. The cell
pellet is re-suspended and 10µl is added on to the agar. The number of cells were
counted using a haemocytometer. For the experiment 23× 103 cells were used.
3.5.1.2 Acquisition Setting
The camera acquisition rate was reduced from the 20kHz to 1 kHz and exposure
time 50µs. The galvanometer is set to scan 2mm in the transverse direction, this
corresponds to 500 A scans. The galvo scan speed is reduced by a factor of 10 this gives
a finer and a more oversampled image. A total of 5000 A scans are collected.
3.5.1.3 Phase Processing
The oversampling is done to permit the phase changes to be calculated. The phase is
unwrapped to remove 2pi ambiguities using the MATLAB ”unwrap” function. Short
Time Fourier Transform (STFT) a specialised adaptation of the Fourier transform is
used to look for the solenoid modulation frequency. STFT is used here because we
seek to spatially localise the origin of the modulation frequency. The STFT sections
the data into multiple segments and performs the FFT on each segment. Prior to
performing the FFTs, a Hanning window is applied to each segment to reduce the
spectral leakage in the spectrum. A pitfall of STFT is the trade off between the
spatial resolution and frequency resolution due to the sectioning of the data. For
a larger section/bin sizes we achieve a better frequency resolution, the modulation
frequency is well defined but the spatial resolution decreases and the accuracy of the
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location of SPIOs decreases. In the experimentations a bin size of 50 points (20µm)
was chosen to optimise the spatial resolution.
Figure 3.7, a flow diagram illustrating the process acquiring a B scan and using it
to compute, the STFT image which maps the locations of the oscillations at 2fB.
These locations are taken to be the locations of the SPIOs and hence that of the
rLEC since the controls(without any SPIOs) give no significant signals above the
background.
77
3.5. AGAR PHANTOMS
Figure 3.7: Process for computing STFT images
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In figure 3.7, a spectrum is plotted at the fifth step in the flow diagram, this is to
check that the magnetic modulation displacements at 2fB are present. If the frequency
fB is not present then, a new B scan can be acquired. However, if a multiple of the
frequency fB is present the STFT would be computed to see which location the signals
are originating from as it may give information about the medium the nanoparticles
are in. The reason for fB not been present can be numerous, including the solenoid
not been aligned underneath the sample correctly. The solenoid not being vertically
aligned with the sample will mean the sample will experience a reduced magnetic
field strength and therefore only be displaced by a small amount; which might be
below the sensitivity of the system. If the frequency fB is present the STFT can
be computed, this stage includes the application of the Hanning window. Following
this the amplitudes corresponding to the frequency fB for each section is found and
inserted into a new matrix to produce a modulation amplitude map. The locations
with SPIOs present have a larger amplitude. We purposely choose a frequency away
from the DC component in the FFT because this will contain any optical phase
changes inherent to the system and not time dependent.
3.5.2 Results
In our results the top layer containing the SPIOs display a higher amplitude than the
rest of the agar phantom. The higher amplitude is due to the larger displacement
experienced by the SPIOs. These results prove that the MMOCT system can be used
to locate SPIOs in 2D. During the experimentation it was observed that interference
from the fluorescent light was leaking into the measurement. The fluorescent light
produces frequencies at twice the mains; 100 Hz and its harmonics. These frequencies
were only present if the measurements were done with the lights on.
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(a) Plot shows 100Hz and harmonics from the lab’s fluorescent tubes
(b) 100Hz and harmonics disappear when the fluorescent lights are
turned off
Figure 3.8: Shows the presence of 100Hz and its harmonics when the lights are kept
on during imaging b) shows the absence of these frequencies when the imaging is done
in a dark room. The colours correspond to different depths in the image
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When taking MMOCT measurements the fluorescent lights in the lab has to be turned
off because the lights produced modulation signals at double the mains frequency and
its harmonics (100Hz, 200Hz, 300Hz...).
The SPIO/milk mixture is at a concentration of 83µg/ml SPIO:milk. 10 µl of the
SPIO/milk solution is added to the surface of the agar phantom.
Figure 3.9: Diagram of SPIO/Milk solution on top of agar phantom
Figure 3.10a shows the images of SPIO mixed with milk, the milk makes the layer
containing the SPIOs visible on top of the agar.
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(a) Structural B scan image of the SPIO/milk solution on the agar
phantom surface. The agar phantom forms a meniscus when it so-
lidifies
(b) FFT computed shows MMOCT signal at 160Hz as expected at
double the fB
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(c) Location map of the SPIO nanoparticles. The SPIO/milk layer
has a higher displacement amplitude compared to the agar phantom.
Figure 3.10: The structural B scan and its corresponding SPIO nanoparticle location
map for SPIO/milk of concentration 83µg/ml.
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In Figure 3.11 the SPIO/milk mixture was allowed to dry in the incubator (temper-
ature= 37oC , CO2 level= 5%) for two hours. The drying process evaporates the
water in milk leaving behind the SPIOs and lipid molecules from the milk. Both the
structural image and the location amplitude map can be seen to have a thinner top
layer due to the dehydration process. The layer appearing thin is due to the section-
ing(window) size used in the STFT. Both results dried and non dried used a window
size of 50 pixels for the STFT, the spatial resolution would have degraded and the
top layer would appear thicker if a larger window size was used.
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(a) Structural B scan image of the SPIO/milk solution on the agar
phantom surface.
(b) FFT computed shows MMOCT signal at 160Hz as expected at
double the fB
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(c) Location map of the SPIO nanoparticles. The SPIO/milk layer
has a higher displacement amplitude compared to the agar phantom.
Figure 3.11: The structural B scan and its corresponding SPIO nanoparticle location
map for dried SPIO/milk of concentration 83µg/ml.
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3.6 Cornea Imaging
This experimentation was the main aim of the project, to be able to embed SPIO
nanoparticles within rLEC and successfully transplant these loaded cells onto a cornea
ex vivo. Then locate the loaded cells on the cornea using our ultra-high resolution
SDOCT in combination with the MMOCT set up. This may play a major role in
the future development of stem cell treatment for LSCD, where the stem cells to be
transplanted can be labelled with SPIOs and tracked using MMOCT system.
3.6.1 Method
Initially a million cells were transplanted on to the cornea. After the success of this,
the cell number was reduced to 250,000 followed by 100,000. These reductions in
the number of cells transplanted was to assess the sensitivity of the system and to
highlight any signal dependence on the population size of the transplanted embedded
cells. The data processing of the rLEC experiment is the same as was done for the
agar experiments. However, here the corneas also have to be prepared. The rabbit’s
eye globe is dissected to leave behind the anterior button (i.e. the cornea surrounded
by 2-3 mm of sclera). The vitreous humour and the lens are removed. The reason
for dissecting the eye globe is for ease of imaging. The eye globe has a small radius
of curvature and the SNR falls off rapidly with lateral position. Dissecting flattens
the cornea and decreases the sensitivity fall off. With the cornea button prepared the
cells with the embedded SPIO nanaparticles can be transplanted onto the cornea. For
this process a cylindrical ring was placed onto the cornea button. After calculating
how much media/cells to draw from the incubation flask, this volume is drawn and
pipetted into the hollow cylinder onto the cornea. The cylinder is used to contain
the cell solution on the cornea and prevent it from running off. This allows the
transplanted cells to anchor onto the cornea. The cylinder is made of stainless steel
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with an inner bore area of 78.5 mm2. As the cylinder is made of stainless steel it was
left in place on the cornea during imaging. The SPIO embedded cells are allowed 1
hour to anchor to the cornea epithelium before imaging.
Figure 3.12: Cornea button prepared for imaging (left) and stainless steel ring placed
on top of cornea to contain the cells embedded with SPIO nanoparticle.
3.6.2 Results
The areas with the high intensities have greater displacements at 160Hz. It is clear
that the higher displacements are seen on the epithelium where the rLEC with the
embedded SPIOs are transplanted. Figure 3.13 illustrates the results for different cell
seeding densities are used. Initially a million cells are transplanted onto the cornea.
This is a large number of cells but it also equates to a higher probability of success.
This was followed by a transplantation of 2.50× 105 cells and finally 1× 105.
This result shows the 1× 106 SPIO embedded cells transplanted onto the cornea. The
top layer containing the transplanted cells embedded with SPIOs is distinguishable
from the rest of the cornea. The number of cells seeded is too high as it has formed
an opaque multi layer, this is evident in figure 3.13a where the stroma is not as clear
as compared to figure 3.14a and figure 3.15a. The epithelium appears bright in the
structural image but the stoma below is darkened from 0.4 to 1.5mm on the width
axis. With this high density of loaded cells, a MMOCT signal was not needed to locate
the region of SPIOS embedded cells. So the seeding number needs to be reduced and
tested to see if the MMOCT system can still detected their location.
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(a) Structural B scan image of the SPIO embedded cells on the cornea
epithelium
(b) FFT computed shows MMOCT signal at 160Hz as expected at
double the field modulation frequency fB=80Hz.
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(c) Location map of the cells containing SPIO nanoparticles. The
epithelium layer of the cornea has a higher displacement amplitude
compared to lower layers
Figure 3.13: Shows the structural B scan and its corresponding SPIO nanoparticle
location map for 1× 106 cells (12732 cells/mm2) embedded with SPIOs transplanted
onto a cornea
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The following results illustrates the MMOCT obtained from transplanting 2.50× 105
cells embedded with SPIO nanoparticles on a rabbit cornea. We do obtain a MMOCT
signal at double the fB. However, we also see a signal at 80Hz and higher harmonics,
the required signal at 160Hz is the most dominant.
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(a) Structural B scan image of the SPIO embedded cells on the cornea
epithelium
(b) FFT computed shows MMOCT signal at 160Hz as expected at
double the fB=80Hz.
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(c) Location map of the cells containing the SPIO nanoparticles. The
epithelium layer of the cornea has a higher displacement amplitude
compared to lower layers
Figure 3.14: Shows the structural B scan and its corresponding SPIO nanoparticle
location map for 2.50× 105 cells (3183 cells/mm2)embedded with SPIOs transplanted
onto a cornea
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Figure 3.15 shows the MMOCT obtained from transplanting 1.0× 105 cells embedded
with SPIO nanoparticles on a rabbit cornea. A strong signal is present at 160Hz but
like figure 3.14 the 80Hz MMOCT signal is also present.
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(a) Structural B scan image of the SPIO embedded cells on the cornea
epithelium
(b) FFT computed shows MMOCT signal at 160Hz as expected at
double the fB=80Hz.
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(c) Location map of the cells containing the SPIO nanoparticles. The
epithelium layer of the cornea has a higher displacement amplitude
compared to lower layers
Figure 3.15: Shows the structural B scan and its corresponding SPIO nanoparticle
location map for 1× 105 cells (1273 cells/mm2) embedded with SPIOs transplanted
onto a cornea
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3.6.3 Discussion
Figure 3.14b and figure 3.15b does not only show signals at 160Hz but also at 80Hz
and higher frequency harmonics. The reason for this is not totally clear. These
harmonics maybe due to the environment in which the particular cells are in. Since
even and odd harmonics can be produced by a mechanical response which varies
non-linearly with the driving field. When comparing the STFT location amplitude
maps figure 3.14c and figure 3.15c to the high cell density sample figure 3.13c; it is
noticeable that for figure 3.14c and figure 3.15c the MMOCT signal is present in not
only the epithelium layer but also in the stroma. A possible reason for the presence
of MMOCT signal in the rest of the cornea could be due to the rLEC containing the
SPIO nanoparticles migrating into the cornea, although a more probable explanation
is the outward diffusion of SPIO nanoparticles from the transplanted cells into the
remaining cornea. These hypotheses can be investigated by imaging the sample more
frequently from the time of seeding the cells on the cornea surface. If this phenomenon
is due to either the diffusion of the SPIO nanoparticles or the migration of the cells,
the image dataset should show a gradually increasing MMOCT at depth with time.
These hypotheses were not investigated due to time restrictions on funding.
3.7 Future Works
For future development it would be critical to both automate and synchronise the
solenoid modulation at fB with the acquisition of frames. Also it would be advanta-
geous to sonicate the SPIO solution before incubating it with the cells for uptake and
also before pipetting the SPIO/milk solution on the agar. The sonication will disperse
the SPIOS, reducing aggregation and giving a more evenly dispersed MMOCT signal.
However, the even after sonicating the SPIO solutions if not used straight away the
SPIOs will aggregate again, so a better direction forwards would be to use dextran
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coated SPIOs which has already been used in animal/human studies. The coating
will reduce the nanoparticle aggregations.
Another aspect which can be improved is the introduction of wavelet transforms
instead of STFT. The wavelet transforms have the resolution advantage over the
STFT. The STFT requires a fixed window size and therefore the tradeoff between
spatial and frequency resolution is fixed but the wavelet analysis allows for flexible
windowing [7].
Another interesting aspect of the research with scope for further development is the
cause of the multiple harmonics. With some samples there are no other frequencies
other than at the expected second harmonic where as other have signal power at
higher harmonics also. More interestingly the nanoparticles used are paragmagnetic
and therefore should be displaced at twice the modulation frequency but some samples
do exhibit oscillations at 80Hz.
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Chapter 4
Oral Mucosal Imaging
4.1 Summary
Optical coherence tomography is now the gold standard technique for retinal screen-
ing and is emerging rapidly in cardiovascular research however it remains a research
goal to establish it to the same degree in epithelial cancer detection and diagnosis. In
this chapter we compare two different OCT systems: an 890 nm spectrometer-based
OCT system with 2.5 µm axial resolution and a 1300 nm swept-source OCT system
with 7.5 µm axial resolution to determine the effect of these different OCT param-
eters on the endogenous backscatter contrast of dysplastic/malignant oral mucosa
models relative to normal mucosa models. Tissue- engineered oral mucosa models
constructed with a dysplastic cell line (DOK), a malignant cell line (Cal27) and nor-
mal cell were imaged with both of these OCT platforms and comparisons made with
regard to apparent epithelial thickness and the visibility of the epithelium relative
to the underlying stroma. For the Cal27s, hematoxylin and eosin staining confirmed
the formation of a keratinized layer superficial to a thickened layer of viable cells on
top of the stroma. The keratinized layer presented as a hyper-reflective thickened
layer superficial to a darker region on both OCT platforms. The keratinized layer
caused a steep fall in signal at 890 nm, making it difficult to visualise underlying
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structures, whereas 1300 nm OCT clearly visualized both the epithelial cells and the
stroma lying beneath. For the DOK cells, hematoxylin and eosin staining confirmed
the formation of an epithelial layer frequently presenting an abnormal morphology es-
pecially at the epidermal/stromal junction, with features such as infiltrating, bulbous
rete pegs. These were more clearly visualized under 890 nm OCT. These observa-
tions show that 890 nm OCT retains some of its known advantages of higher contrast
between anatomical tissue layers when used to observe dysplastic and malignant 3D
oral mucosa constructs. However, 1300 nm OCT is confirmed to possess a greater
ability to image the full thickness of the model epithelia and in particular it is more
suited to imaging through the keratinized layer.
4.2 Introduction
The work in this chapter has been published in the Modern Technologies in Medicine
Journal [1].
Optical Coherence Tomography in the medical field was originally used in ophthal-
mology. It is now the gold standard technique for retinal screening. However, its
applications in the screening of superficial cancers is now becoming a focus in re-
search. Using OCT to image cancerous tissues at depths can be very challenging
due to the scattering nature of tissues. The highly scattering tissue layers limits
the imaging depth of the OCT. However, this is not such a disadvantage in epithe-
lial cancer detection since generally the epithelium is only a few hundred microns
in thickness. In this chapter we compare two different OCT modalities: the Ultra-
high resolution 890 nm spectral domain (SD) OCT system and a commercial 1300
nm swept-source (SS) OCT system. The 890nm SDOCT as described in the chapter
”Ultra High Resolution Spectral Domain OCT (UHR-SDOCT) for corneal imaging”
has an axial resolution of 2.5 µm in air whilst the commercial 1300nm SSOCT has
an axial resolution of 7.5 µm in air. In the chapter histology images are used to
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show the morphological changes between the normal, dysplastic and carcinoma mod-
els. Histology is the gold standard for determining the abnormalities in the cell’s
nuclear morphology, a recognised marker for dysplastic changes [2] [3]. OCT is used
to establish the gross cellular structure and the extent of the tumour. It known that
OCT systems with light sources producing a central wavelength below 1 µm and a
bandwidth larger than 150 nm will have an advantage in terms of axial resolution.
However, systems with central wavelength greater than 1 µm usually 1300nm provide
better depth penetration due to the lower attenuation at the longer wavelengths. In
this study we compare the OCT presentation of three tissue-engineered oral mucosa
models using an 890 nm SLD-based spectrometer system and a commercial 4-beam
swept-source system operating at 1300 nm. The aim in this experimentation was
to determine the effect of different central wavelengths and axial resolution on the
endogenous backscatter contrast of dysplastic/malignant oral mucosa models relative
to normal mucosa models. This experiment will also allow us a direct comparison of
the in-house UHROCT system to a commercial used system.
4.3 Method
For the experimentations oral mucosa models were constructed from dysplastic cell
line (DOK), a malignant cell line (Cal27) and normal cells. These models were then
imaged using both of these OCT modalities and a comparison made between their
measurements of the epithelial thickness and the overall visibility of the epithelium
relative to the stroma.
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4.3.1 1300nm SSOCT
The 1300 nm swept source (laser sweeps through wavelength band) OCT system(EX1301,
Michelson Diagnostics Ltd., UK) is a multi-beam set-up with four independently fo-
cused sample beams. The swept source laser used is the HSL-2000-10 by (Santec,
Inc.,Japan). The source provides a centre wavelength of approximately 1300 nm with
an approximate bandwidth of 150 nm. The 1300 nm system produces B scans of
the samples at a rate of 10,000 A scans per second. The system is also capable of
acquiring B scans comprising of different number of A scans. The 890 nm system has
a maximum lateral scan distance of 4mm whilst the 1300 nm system’s lateral scan
distance can cover up to 6mm. In this experiment a lateral scan distance of 4mm was
used for both systems. The axial resolution of the SSOCT as measured in air is 7.5
µm and a lateral resolution of 7.5 µm also. In the study B scans acquired comprised
of 952 A-scans over a lateral distance of 4mm. Acquisition was at a rate of 5 frames
per second. The EX1301 has a stitching algorithm which combines the best focused
regions from the four independently focused beams to form a composite image with
a two-fold lateral resolution improvement as compared to a single beam imaging the
same region [4]. This system is a good standard to compare the 890nm in-house
system to because the 1300nm system has been used in clinical setting to identify
malignant oral mucosa biopsy samples. The system achieved a sensitivity (ratio of
correctly detected positives to total number of positives)of 85% and specificity (ratio
of correctly detected negatives to total number of negatives) of 78% when used to
image biopsy samples in an immediate ex vivo study [5].
4.3.2 890nm UHR-OCT
The 890 nm system used for imaging oral mucosa models is a custom-built ultra-
high resolution spectral domain optical coherence tomography system. A dual super
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luminescent diode source (Broadlighter D890-HP, Superlum, Ireland) emits a central
wavelength of 890 nm and a bandwidth of 150 nm into the single mode fibre based
system. The details of the set up and imaging parameters are recorded in section
2.5.
4.3.3 Tissue Models Preparation
The tissue preparation was conducted by colleagues John Fernandes and S Mittar,
PhD and the histology images were provided and used with the permission of Vanessa
Hearnden, PhD. The experiments were supervised by S. MacNeil, M.H. Thornhill, C.
Murdoch, PhD, K.D. Hunter, PhD and S.J. Matcher.
The group led by Prof. Sheila MacNeil have successfully developed 3D models of
healthy human oral buccal mucosa for clinical applications. The model consisting
of a base of connective tissue with an upper epithelium layer has been used as re-
placement for scar tissue in the urethra [6]. A similar process is used to build the
dysplasia and carcinoma models but the healthy oral keratinocytes are replaced with
dysplastic and malignant cell lines respectively. All the work to generate the tissue
models were carried out in sterile condition in class(II) laminar flow tissue cabinets
(Walker Safety Cabinets, UK). During tissue culturing the cells were kept in humid-
ified incubators at 37oC containing 5% CO2. The tissue models were cultured on an
acellular skin scaffold processed from glycerol treated cadaveric skin purchased from
Euroskin Bank (Beverwijk, the Netherlands). To preserve the skin until it is used, it
was stored in glycerol and kept at 4oC. Before use the models were washed in sterile
phosphate buffer solution repeatedly to remove the glycerol and then incubated in
1M sodium chloride for 1 day. The epidermis from the skin was removed, produc-
ing a de-epithelialised dermis (DED). The remaining DED was used as scaffold for
tissue engineered oral mucosa models. The DED was dissected into 1.5 by 1.5 cm
squares and placed into a 6 well plate. The cylindrical rings are placed on top of
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the DED, the rings have some weight to them so it settles into the DED forming a
liquid tight seal between the bottom of the ring (in contact with the DED) and the
DED. Both Normal Oral Keratinocytes (NOK) and Normal Oral Fibroblasts (NOF)
were isolated from waste tissue collected during routine oral surgery (Ethics reference
09/H1308/66) as described by Colley [7]. They were then seeded into the cylindrical
ring wells at a ratio of 3:1 ratio. The ring has a 1 cm diameter and a height of 1 cm,
hence, seeding 300,000 NOK to 100,000 NOF in Greens media. After 48 hours, the
seeding the composites are elevated to air /liquid interface using square stainless steel
grids. The composites are then cultured for another 7, 14 and 21 days. To produce
the abnormal mucosal models, the Cal27 oral squamous cell carcinoma and the DOK
pre invasive cell lines were used. The process for producing these were identical to
that used for the normal mucosal models, however, only 250,000 cells of each type
were used along with the 100,000 NOF. Each model was grown in media associated
with the cell line used. The Cal27, derived from the tongue is an oral squamous
cell carcinoma human cell line was cultured in DMEM with 10% FCS. The Cal27
cells used was purchased from ATCC (Manassas, VA, USA). The Dysplastic Oral
Keratinocytes (DOK, ECACC 94122104) were acquired from the European Collec-
tion of Cell Culture (ECACC) via Sigma Aldrich (Dorset, UK). The DOK cell line
was obtained from a tongue lesion. The lesion next to oral squamous cell carcinoma
exhibited mild to moderate dysplasia. The DOK cells were also cultured in DMEM
with 10% FCS supplemented with hydrocortisone (5 µg/ml). The abnormal models
were also cultured for 7, 14, and 21 days.
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4.4 Results
4.4.1 Oral mucosa models histological assessment
During the development of the models it was observed that the thickness of the
epithelium and the degree of stratification is dependent on the duration the models
are cultured at an air/liquid interface for [7] [8].
Culturing the tissue engineered oral mucosa at an air liquid interface produces a
stratified epithelium after 7 days in culture figure 4.1. The epithelium is 10 cell layer
thick by the 21st day and displays signs of organisation and differentiation. Over time
in culture, the model becomes more organised and the epithelium becomes thicker.
Comparing the hematoxylin and eosin (H&E) stained histology sections it is apparent
that there are similarities between the tissue-engineered model and the human biopsy
figure 4.2. One main similarity is the differentiation pattern observed in-vivo is also
observed in the tissue engineered oral mucosa.
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Figure 4.1: H&E stained histology of normal tissue-engineered oral mucosa over 7
(a), 14 (b) and 21 (c) days of culture at an air/liquid interface. Reproduced with
permission from Hearnden [8]. Scale bar: 100 µm
Figure 4.2: H&E stained histological comparison of the normal TEOM (a) with an
in vivo biopsy of healthy oral mucosa (b). Reproduced from Hearnden [8] with per-
mission. Scale bar: 100 µm
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The basal cells in the basal layer of the epithelium have a high density of nuclei. As
the cells begin to differentiate their nuclei are more dispersed, this can be seen in the
supra-basal cells. They are larger and their nuclei are more dispersed. Layers at the
surface contain cells which are flattened with very dispersed nuclei. These superficial
cells are terminally differentiated and produce the smooth flat surface of the epithe-
lium. Both sets of samples, the human biopsy and the tissue engineered oral mucosa
(TEOM) have rete ridges, the characteristic rounded extensions protruding into the
epithelial connective tissue and forms the epithelial connective tissue junction.
It is noticeable that intracellular signalling plays a part in the evolution of the ep-
ithelium because the cells of the epithelium differentiate in strata and not individu-
ally.
4.4.1.0.1 DOK model
Below Figure 4.3(a)(f) shows the stages of development of the 3D tissue engineered
models resulting from DOK cells cultured on an acellular skin scaffold. DOK cells
begin to form an epithelium layer of thickness 2-10 cells by the 7th day of culturing
at air/liquid interface. In some areas there are signs that cells have not been able to
differentiate into strata and various areas show signs of cell death. After culturing for
14 days the thickness of the epithelium has increased compared to the previous mea-
surement at day 7. The measurement was done taken 2D B scans using OCT, where
the epithelium can be distinguished from surrounding tissue due to the difference
in refractive indices. The thickness is then measured from the image using ImageJ
version 1.47. The epithelium strata is now showing signs of organising themselves.
Some of the superficial cells are becoming flattened and their neighbouring connective
tissue are starting to organise into a pattern seen in normal epithelia. There are also
signs of dysplasia where individual cells are producing keratin instead of strata of cells
and also nuclei pleomorphism is present throughout the epithelium (this can indicate
severe dysplasia or carcinoma). Significant cytological structural abnormalities are
observed in the basal layer which commonly indicates carcinomas (highlighted region
109
4.4. RESULTS
of figure 4.3 (d)). A severe dysplastic and carcinoma appearance alongside cytological
and structural abnormalities throughout the epithelium are apparent by day 21. The
abnormalities include: rete pegs which are extensions into the connective tissue and
keratin pearls which are circular formations of keratin(stained pink by H&E) in the
middle of the epithelium. There are regions of cells within the stroma which have the
appearance of epithelial cell invading the stroma. The alien cells appear different to
fibroblasts in the connective tissue as fibroblasts tend not to cluster in a group as the
cells seen in these models do and there is hematoxylin staining around the cells (not
seen for the fibroblasts).
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Figure 4.3: H&E stained histological sections of the DOK cell line cultured in three
dimensions on DED. Models were grown at an air/liquid interface for 7 days ×10
magnification (a) and ×20 magnification (b); 14 days ×10 magnification (c) and
×20 magnification (d) or 21 days ×10 magnification (e) and × 20 magnification (f).
Highlighted circle (d) shows invading cells. Arrows (e) show invaded tumour islands.
Scale bar: 200 µm (n=3). Reproduced from Hearnden [8] with permission
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4.4.1.0.2 CAL model
Figure 4.4 shows CAL27 model these are most comparable in appearance to that
of clinical dysplasia and carcinoma. Within 7 days in culture the epithelium is ob-
served to be differentiated with well defined basal cell layer. The differentiation takes
place in regions and strata of the epithelium rather than in isolated cells indicating
some cell-cell interactions. Islands of epithelial cell are found within the connective
tissue suggesting invasion of the oral squamous cell carcinoma into the connective
tissue.
The models cultured for 14 days appear highly keratinised on the surface. This high
level of keratinisation is also commonly seen on the surface of dysplastic tissues clini-
cally. Figure 4.4(c) shows the organised differentiation remaining in areas however, in
other places this is disrupted by the extensive keratinisation. After 21 days in culture
the appearance of the histology is less like dysplastic lesions seen clinically as cells
begin to grow over the top of the keratinised areas and the differentiation is mostly
lost. This model has the appearance of a squamous cell carcinoma in situ with some
signs of invasion as early as 7 days at air/liquid interface.
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Figure 4.4: H&E stained histological sections of the Cal27 cell line cultured in three
dimensions on DED. Models were grown at an air liquid interface for 7 days ×10
magnification (a) and ×20 magnification (b); 14 days ×10 magnification (c) and ×20
magnification (d) or 21 days ×10 magnification (e) and ×20 magnification (f). Scale
bar: 200 µm (n=3). Reproduced from Hearnden [8] with permission
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4.4.2 Oral mucosa models OCT presentation at 890 and 1300
nm
.
Figure 4.5 shows OCT two dimensional B-scans collected on the normal, dysplastic
and carcinoma oral mucosa models at day 21. It is evident that the 890 nm images in
general appear darker and have a greater roll-off in sensitivity with depth compared
to the 1300 nm images. This may be inherent from the different system parameters,
however, it is obvious from comparing image figure 4.5(c) with figure 4.5(f) that there
is also a better contrast between the tissue-engineered epithelium and the DED when
imaging at 890nm and with 2.5µm axial depth resolution compared with imaging at
1300nm. For this study this improvement in axial resolution means there is a better
ability to infer the epithelial thickness and, for the DOK model shown in figure 4.5(c)
there is a clearer ability to resolve morphological abnormalities such as infiltrating,
drop shaped rete pegs similar to those shown by histology in figure 4.3.
For the Cal27 models we see an inversion of the usual contrast pattern for OCT
images of epithelium, with the most superficial band appearing brighter than the
underlying layers. With the in house-built 890nm system the superficial layer is
significantly brighter than the corresponding layer in the normal model and displays
a sharp, irregular lower border indicative of strong contrast between this layer and
the underlying material. Even fainter signal is visible below this underlying layer,
particularly towards the image centre. Based on our previous experience with OCT
imaging of tissue-engineered skin [9], we consider that a plausible interpretation of
the Cal27 images is that the brighter superficial region represents keratinized tissue
overlying the metabolically active dysplastic epithelial cells (which generally present
more darkly than stroma in OCT images). Such keratinization is a late-stage feature
of the Cal27 models as seen in figure 4.4 as well as being a common clinical feature
of dysplastic oral lesions. There are small dark infiltrations at the surface of model
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(especially clear on the 890 nm image), which may be areas of nascent epithelial cell
overgrowth. The weak signal seen deep in the Cal27 model may be the remnants
of signal from the underlying DED, which is now deep below both the keratinized
superficial layer and a thickened layer of epithelial cells. The DOK construct was
imaged at day 21. 573 slices were acquired, each 4 mm wide and with 5 micron
slice spacing. Data was collected sequentially on the two systems. Fiducial markers
were placed on the epithelia surface of the construct, to facilitate the approximate
registration of the two data sets. It is clear that the 1300 nm image shows more signal
from deeper regions of the stroma whereas the 890 nm image more clearly demarcates
the epithelial thickness, epidermal/stromal junction and epidermal infiltrations into
the stroma.
Figure 4.5: Three oral mucosa models imaged using 890 nm (upper row) and 1300
nm OCT (middle row). Scale bar: 1 mm. Contemporary histology shown on the
lower row
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4.5 Conclusions
It is evident that the 890nm and the 1300nm OCT systems give different levels of con-
trast between the epithelium and the stroma in both the normal and dysplastic mod-
els. The general trend appears to be that the 890nm house built system shows greater
contrast between different layers, for the normal and DOK models we see higher con-
trast at the epithelium/stroma boundary and for the carcinoma models(CAL27) we
see the higher contrast at the keratinized/epithelium/ stroma boundaries. Due to the
low attenuation at the higher wavelength, the 1300nm system shows a better depth
penetration and a more uniform contrast across the imaging depth. This is explained
by the scattering coefficient been proportional to λ4 This is in agreement with earlier
in vivo studies on normal human skin [10].
This study has shown that the UHROCT is comparable to the commercially available
system in imaging biological scattering tissues. The system performs as well and even
provides better contrast so can also be used to classify normal tissues from dysplas-
tic and carcinoma tissues. The study also shows the potential for dual wavelength
imaging as a route to improve the imaging of oral lesions, the 890nm channel provid-
ing the axial resolution to reveal morphological irregularities and the 1300nm channel
providing improved sensitivity to structures at depth including vasculature [11].
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Chapter 5
Differential epidermal thinning of
human forearm volar skin after
steroidal and non steroidal
treatments
5.1 Summary
In this chapter we conduct a quantitative study on the effect of two commercially avail-
able topical creams for the treatment of eczema using a 1300 nm central wavelength
optical coherence tomography system. In the study we compare Betamethasone valer-
ate a corticosteroid with Tacrolimus monohydrate a non-steroidal anti-inflammatory
drug using a left/right comparison of epidermal thickness of the volar forearm skin
on selected volunteers at baseline and after 14 days of treatment. We observed in 3
out of 4 volunteers that the use of corticosteroid results in the physical thinning of
epidermis during a few weeks. It was also noted that in 3 out of the 4 volunteers
Tacrolimus produced no physical changes in the epidermal thickness, however 1 out
of the 4 volunteers showed evidence of the epidermis actually thickening following the
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application of Tacrolimus.
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5.2 Introduction
The skin acts as a barrier layer to regulate against fluid loss and pathogen invasion.
The barrier function is most prominent in the most superficial layer of the skin:
the stratum corneum. The stratum corneum is composed of keratinized corneocytes
which are physically bonded together by corneodesmosomes. The stratum corneum
typically has a thickness of 15-20 layers, the thickness is maintained by desquamation
(the removal of the superficial layer of the stratum corneum) and this is balanced
by the constant production of keratinocytes in stratum basale [1]. It thought that
the breakdown of these corneodesmosomes is a key factor in the initiation of barrier-
degrading inflammatory condition such as atopic dermatitis. The breakdown can be
due to degradatory proteases.
A strong link has been established between the loss-of-function mutations in the FLG
gene and being predisposed to atopic dermatitis [2]. FLG encodes for the production
of filaggrin, a protein that facilitates the formation of the skin barrier. The filaggrin
protein aids the formation and maintenance of the barrier function through several
aspects including the mediation of keratin intermediate filament production and as
a source of water-binding amino acids in the stratum corneum. It is believed that
a skin barrier dysfunction is a precursor to clinical atopic dermatitis [3]. This link
was established whilst measuring the transepidermal water loss (TEWL) in children,
the study showed that TEWL was higher for atopic dermatitis sufferers but not
for sufferers of other allergic skin conditions [4]. The conclusion was that children
suffering from atopic dermatitis had a higher TEWL. This led to the suggestion of
treating atopic dermatitis with barrier enhancing emollient alongside, or possibly as a
replacement for, topical corticosteroids. A study conducted by Wiren and colleagues
showed that after treating lesions with Betamethasone Valerate the recurrence of
eczema can be delayed by using a skin moisturiser [5]. There is a growing interest in
the use of non-steroidal anti-inflammatory drugs and more specifically targeted anti-
inflammatory agents such as the calcineurin inhibitors for the treatment of atopic
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dermatitis [6]. Tacrolimus monohydrate used in our study is such a drug which has
reached clinical usage (Protopic ®, Astellas Pharma). Another supporting reason
for the use of Tacrolimus and other non-steroidal treatment is the low percentage
of unwanted side effects such as atrophy and pigment alteration [7], experienced
in comparison to when corticosteroids are used. It is therefore of great interest to
quantitatively asses the effect such treatments have on the skin layer thickness. Due
to it’s micron resolution, optical coherence tomography (OCT) is used routinely in
skin imaging in regards to the epidermis. In our study OCT is used to measure the
thinning of epidermis and dermis, OCT is non invasive and has a high contrast to
differentiate between the anatomical skin layers.
Previous investigations using OCT alone or along with US have been conducted to
study the effects of topic corticosteroids on the skin thickness. One of the earliest
studies, applied clobetasol proprionate 0.05% (potency class IV) for 3 weeks on a
daily basis and the skin was imaged both before and after the treatment using a
multi-channel time domain OCT [8]. The epidermis appeared as a thin layer with
thickness around 100 µm on top of the dense dermal layer. Corticosteroid induced
atrophy was observed as a decreased in the mean epidermal thickness from 74 to
61 µm. OCT in conjunction with ultrasound (US) has been used to quantify the
effects of different topical corticosteroid (TCS) compounds epidermal and dermal
thickness [9]. The effects due to the daily application of 50 mg of TCS compounds
in potency classes I-IV plus placebo (steroid-free cream base) were studied at time
points of 0, 3, 7, 14, 21, 28 days and 3-months. Interestingly a reduction in mean
epidermal thickness of >20% was observed for all 4 TCS compounds and placebo
and control measurements however the effect was more evident with increasing TCS
potency. The design of the experiment meant that the control site was adjacent to
the five sample sites which could lead to cross contaminations. A further analysis
showed that there was no correlation between the thinning at the control site and the
potency of the TCS compound applied to the adjacent site (which was randomized
between subjects). The authors postulated that the thinning of the control site was a
systemic effect. This pattern was also observed in the dermal thickness but to a lesser
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extent. The weaker response demonstrates the advantage of OCT’s higher resolution.
Also the epidermis is fundamentally a more sensitive maker to skin atrophy and hence
shows changes at earlier stage.
Both the ultrasound and OCT systems showed a recovery of skin layer thickness
towards the baseline between the end of the treatment at day 28 and the final 3 month
time point. The effects of twice daily application of clobetasol proprionate 0.05%
over a 14 day period has been studied in a cohort of 13 young female volunteers [10].
OCT showed that the TCS produced significant epidermal thinning over the 14 days
and also showed a recovery to baseline after the end of the treatment. An increase
in stiffness and reduction in viscoelasticity were measured using mechanical testing,
these effects were also reversible at the end of the treatment.
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5.3 Method
A small cohort pilot study was undertaken consisting of 4 healthy volunteers, none
of whom had any contraindications for treatment using either compound. Ethical
consent was obtained from the Sheffield NHS Trust. The treatment protocol was as
follows. The measurements were done on the volar forearm skin. The left hand of the
volunteers was chosen to receive either the TCS or the non steroidal anti-inflammatory
drug (NSAID) and the right arm received the other compound. Volunteers were
unaware of which arm received which drug until the data analysis was completed.
Measurement of each subject was done before the commencing of the study and at
the end of the treatment (day 14). The actual treatment consisted of covering the
entire forearm with 2 fingertip units (FTU) of cream twice daily [11].
Three different measurement protocols were employed in the progression of the pilot
study. Firstly, for subject 1, a single measurement site was scanned prior to the
treatment and at the end. Natural anatomical markers such as moles were used as
location references to allow the measurement site to be revisited for measurement at
the end of the treatment. Secondly for subject 4 the site imaged at the beginning of
the study was maintain for future imaging by using ink markers. Further more a 3 ×
3 grid of measurements was collected at the end of the study. The midpoint between
the elbow and the wrist was marked with a pen, then a rectilinear grid of points with
1.5 cm spacing in both the distal/proximal and lateral/medial directions was marked
out. A single B scan image was collected at each grid point; the scan orientation was
always along the distal/proximal line. The measurements were done for subjects 2
and 3 at baseline and post-treatment.
For subjects 2, 3 and 4 the imaging was done on a commercial multi-channel OCT
system (Michelson Diagnostics Ltd EX1301). The system is swept source based OCT
using a Santec HSL-2000 swept laser with a sweeping range of 150 nm around 1310
nm. The system has improved lateral resolution due to its four independently focussed
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sample beam. The images from each beam are stitched together using a proprietary
algorithm to produce an image with resolution of 7.5 µm in both the axial and
lateral direction. For subject 1 a home built modified version of this system was
used. A home built fibre interferometer which used Thorlabs’ LSM03 OCT objective
to illuminate the sample however the light source, data acquisition hardware and
software were the same as that used on the other subjects. B scans from this modified
system yielded a lateral resolution of around 18 µm.
Quantitative data analysis of the epidermal thickness of subjects 2-4 were carried
out by an independent operator who was blind to the hypothesis under test. The
epidermis shows up as a hypoechogeneic layer situated on top of the brighter dermal
layer. To help with the accuracy in measuring the epidermal thickness each image
was rotated to get the epidermis layer to be horizontal. After the rotation a polygon
region of interest tool was used to manually select the epidermal layer. Both of these
processes were completed using ImageJ version 1.47. The geometric area and lateral
extension of this region of interest was also measured using Image J. Figure 5.1 shows
the original B scan and the rotated B scan with the highlighted ROI.
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Figure 5.1: Raw B scan (above figure)and the rotated B scan with the epidermis
(ROI) highlighted
The ratio of the geometric area and the lateral extension was then used to calculate
the mean epidermal thickness. Some B scans were excluded in the calculations if the
operator could not clearly identify an epidermal layer extending over at least 25% of
the total B-scan.
A paired two-sided Student t-test was conducted to test the null hypothesis that the
means of each grid were identical. The data was paired into matching sites on the
forearm, before and after treatment. In the case of subject 4 a grid of values was
not available at the baseline so to make use of this, a comparison between equivalent
regions on the left and right forearms was done. This comparison would identify if
there was a significant difference in the left and right epidermal thickness after the
treatment.
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5.4 Results
Below are individual B scans of before and after treatment for subject 1.
Figure 5.2: B scans before(upper row)and after (lower row) 14 days of treatment with
(left column) Tacrolimus and (right column) BMV.
From figure 5.2 it is clearly evident that the epidermis after treatment with BMV
image is thinner, compared to the upper right image recorded at baseline. This
suggest that the Betamethasone valerate (BMV) has lead to epidermal atrophy. An
interesting observation is also made on the dermis. The backscatter appears more
heterogeneous making the image penetration depth seem greater. This effect is also
observable in figures 3 & 4 of Cossmann and Welzel [9] and hence may indicate
disruption of the dermal collagen structures, in addition to epidermal thinning. This
should be further investigated. It is possible that the BMV alters the scattering
coefficient of the dermis and hence light travels deeper.
With the 3 × 3 grid data for volunteers 2 and 3 a quantitative comparison was done,
using the methods previously described. The tables in table 5.1 shows the mean
(across all valid sites) epidermal thickness prior to and after treatment for both fore-
arms. The left table is for subject 2 and the data for subject 3 is in the table on the
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BMV Tacrolimus
Pre- 89 ± 0.5 µm 83 ± 0.5µm
Post- 69 ± 0.5µm 83 ± 0.5µm
p-value 0.002 0.88
BMV Tacrolimus
Pre- 74 ± 0.5µm 74 ± 0.5µm
Post- 59 ± 0.5µm 83 ± 0.5µm
p-value 0.01 0.01
Table 5.1: Table showing mean pre-/ post epidermal thickness measured over 3 × 3
grid site for subjects 2 and 3. The p-values are also calculated
right.
The data from subject 2 rejects the null hypothesis and support the alternate hypoth-
esis that the mean epidermal thickness falls by around 25% by the end of the 14 days’
treatment with BMV. However, the null hypothesis is accepted with 88% confidence
for the Tacrolimus measurements, hence is supports the view that the non steroidal
cream does not produce epidermal atrophy. The data from subject 3 also supports
the hypothesis that BMV treatment produces epidermal atrophy, observing a 20% re-
duction in the epidermal thickness after 14 days of treatment. Interestingly the null
hypothesis is also rejected for the Tacrolimus treatment with an apparent increase in
mean thickness of around 13%. To our knowledge such epidermal hypertrophy caused
by Tacrolimus treatment has not previously been reported and is worthy of a more
detailed study.
In order to gain quantitative data from subject 4, where a grid was only measured
post-treatment, we used a pair t-test comparing matching sites on the left and right
forearm. The results are displayed in the tables 5.2. Tables 5.2(a) and 5.2(b) shows
the pre and post data for the left(one compound) and right forearm(other compound)
for subject 2 and 3 respectively. Table 5.2(c) shows the data for subject 4.
The data from subject 2 accepts that null hypothesis that the forearms have identical
epidermal thickness prior to any treatment, however, it rejects this hypothesis after
treatment due to the pronounced atrophy due to the BMV. Similarly, the data from
subject 3 accepts the null hypothesis pre-treatment but rejects it post treatment
even more emphatically partly due to the hypertrophy caused by the Tacrolimus in
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Pre- Post-
BMV 89±0.5 µm 70±0.5 µm
Tacrolimus 84±0.5 µm 83±0.5 µm
p-value 0.18 0.02
(a) Left and right forearm comparison
data for subject 2
Pre Post
BMV 74± µm 60± µm
Tacrolimus 74± µm 85± µm
p-value 0.99 0.005
(b) Left and right forearm comparison
data for subject 3
Pre- Post-
BMV 96± µm
Tacrolimus 96± µm
p-value 0.92
(c) Left and right forearm comparison
data for subject 4
Table 5.2: Tables showing t-test comparison between left and right forearm with a
different compound on each arm
addition to the atrophy due to the BMV. Subject 4 appears not to have any response
to either compound since the epidermal thickness of the left and right forearm are
identical. The non responder conclusion is drawn because it seems very unlikely that
both the left and right arm decreased or increased by the same amount given the
results from the previous patients.
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5.5 Conclusion
In our study we have confirmed reports that epidermal atrophy due to corticosteroids
cream produce significant reduction in the epidermal thickness as detected by OCT.
Furthermore, we have shown that a popular non- steroidal alternative, Tacrolimus
monohydrate, does not produce such thinning in any of the four volunteers. Inter-
estingly we have found that the drug may cause epidermal hypertrophy(1 out of 4
subjects) which deserves further investigation. We also identified a single non- re-
sponder out of the four test subjects, it may be of use to investigate the prevalence
of such subjects.
From comparing the results obtained to previous studies, we can conclude that OCT
is a useful tool for comparison of skin atrophy of steroidal and non-steroidal anti-
inflammatory skin treatments.
130
References
[1] P. Ovaere, S. Lippens, P. Vandenabeele, and W. Declercq, “The emerging roles
of serine protease cascades in the epidermis,” Trends in biochemical sciences,
vol. 34, no. 9, pp. 453–463, 2009.
[2] C. N. Palmer, A. D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, S. P. Lee,
D. R. Goudie, A. Sandilands, L. E. Campbell, F. J. Smith, et al., “Common
loss-of-function variants of the epidermal barrier protein filaggrin are a major
predisposing factor for atopic dermatitis,” Nature genetics, vol. 38, no. 4, pp. 441–
446, 2006.
[3] C. Flohr, K. England, S. Radulovic, W. McLean, L. Campbell, J. Barker,
M. Perkin, and G. Lack, “Filaggrin loss-of-function mutations are associated
with early-onset eczema, eczema severity and transepidermal water loss at 3
months of age,” British Journal of Dermatology, vol. 163, no. 6, pp. 1333–1336,
2010.
[4] J. Gupta, E. Grube, M. B. Ericksen, M. D. Stevenson, A. W. Lucky, A. P. Sheth,
A. H. Assa’ad, and G. K. K. Hershey, “Intrinsically defective skin barrier function
in children with atopic dermatitis correlates with disease severity,” Journal of
Allergy and Clinical Immunology, vol. 121, no. 3, pp. 725–730, 2008.
[5] K. Wire´n, C. Nohlg˚ard, F. Nyberg, L. Holm, M. Svensson, A. Johannesson,
P. Wallberg, B. Berne, F. Edlund, and M. Lode´n, “Treatment with a barrier-
strengthening moisturizing cream delays relapse of atopic dermatitis: a prospec-
131
REFERENCES
tive and randomized controlled clinical trial,” Journal of the European Academy
of Dermatology and Venereology, vol. 23, no. 11, pp. 1267–1272, 2009.
[6] E. L. Simpson, “Atopic dermatitis: a review of topical treatment options,” Cur-
rent Medical Research & Opinion, vol. 26, no. 3, pp. 633–640, 2010.
[7] A. Coondoo, M. Phiske, S. Verma, and K. Lahiri, “Side-effects of topical steroids:
a long overdue revisit,” Indian dermatology online journal, vol. 5, no. 4, p. 416,
2014.
[8] A. Pagnoni, A. Knuettel, P. Welker, M. Rist, T. Stoudemayer, L. Kolbe, I. Sadiq,
and A. Kligman, “Optical coherence tomography in dermatology,” Skin Research
and Technology, vol. 5, no. 2, pp. 83–87, 1999.
[9] M. Cossmann and J. Welzel, “Evaluation of the atrophogenic potential of dif-
ferent glucocorticoids using optical coherence tomography, 20-mhz ultrasound
and profilometry; a double-blind, placebo-controlled trial,” British Journal of
Dermatology, vol. 155, no. 4, pp. 700–706, 2006.
[10] G. Josse, C. Rouvrais, A. Mas, M. Haftek, A. Delalleau, Y. Ferraq, F. Ossant,
J. George, J. Lagarde, and A. Schmitt, “A multitechnique evaluation of topical
corticosteroid treatment,” Skin Research and Technology, vol. 15, no. 1, pp. 35–
39, 2009.
[11] Z. Lu, J. Boadi, S. Danby, M. Cork, and S. J. Matcher, “Optical coherence
tomography demonstrates differential epidermal thinning of human forearm volar
skin after 2 weeks application of a topical corticosteroid vs a non-steroidal anti-
inflammatory alternative,” pp. 85650C–85650C, International Society for Optics
and Photonics, 2013.
132
Chapter 6
Appendix
6.1 Photographs of Ultrahigh resolution OCT
Figure 6.1: Plan view of the Ultrahigh resolution system
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6.1. PHOTOGRAPHS OF ULTRAHIGH RESOLUTION OCT
Figure 6.2: Superlum Broadlighter D890 HP light source
Figure 6.3: The Aviiva CCD mounted on a six degree movement stage
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Figure 6.4: Sample arm housing the galvo scanning mirror and the telescentric lens
6.2 Phase Processing
MATLAB script for Phase processing
close all
fclose all
clear variables;
clc
name=['joseph'];
while name==['joseph'];
% ********************************************************
% [1] Parameter initialization
% ********************************************************
disp('* Parameter intitialization');
% default data folder ----
% PLease edit here according to your own data folder path ----
folder = 'G:\Conc3usingsmallEM';
% folder = 'C:\Documents and Settings\User\My Documents\LabVIEW Data\previous files\New Folder';
% exposure time /us
expo=50.016
% Scanning length <<xm>> should rewrite here
xm = 1; % width in mm
---
*************
zm = 2.9638; % depth in mm in air
% Refractive index depending on your sample
n = 1.44;
treshold = 0.10;
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% select save processed data or not
savedata = 0;
% Optical input channel as from MD detection board
channel = 1;
% Number of samples per A-scan, as selected in image4
Ascansamples = 1024;
% Kazai autocorrelation equation parameters
de = 2; % depth
wi = 4; % width
% Select .oct raw data file(s) to compute
clear RDfolder RDfilelist
[RDfile RDfolder] = uigetfile({'*.oct', 'MD raw data (oct)'; ...
'*.*', 'All files'}, 'Select .OCT raw data file to process', ...
folder, 'multiselect', 'off');
if eq(RDfolder,0)
% User press cancel - script interrupted
disp('* Window closed - script interrupted');
return
end
% ********************************************************
% [3] Compute the .oct file
% ********************************************************
disp(['* Compute .oct raw data file: ', RDfile]);
% Open selected file
fidOCT = fopen(fullfile(RDfolder, RDfile), 'r', 'b');
if fidOCT == -1
% Error in opening the file!
disp('*** File open error! - script interrupted');
return
end
% Read the first part of header (4 bytes: 'M', 'D', format version '2' and variant '0';
% and use them to match the image data; % see MD documentation for details)
H0 = fread(fidOCT, 2, '*char')';
H1 = fread(fidOCT, 2, 'int8')';
if ( (strcmp(H0,'MD') == 0) | | (H1(1)~= 2) | | (H1(2)~= 0) )
disp('*** The data file is not compatible with this script - please use the correct script. For assistance contace Zeng Lu');
return
end
clear H0 H1 % fseek(fidOCT, 4, 'bof');
% Read the content of the configuration string (data as in .ini file)
l = fread(fidOCT, 1, 'long'); % Length of configuration string
Hstring = fread(fidOCT, l, '*char')';
% Extract the averaging factor value
avgfac = str2double(Hstring(findstr('AveragingFactor=', Hstring)+length('AveragingFactor=')));
disp(['- Frame average factor: ', num2str(avgfac)]);
% Number of acquired slices: slices;
% - slices = 1 - single tomography
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% - slices > 1 - multislices tomographies
slices = fread(fidOCT, 1, 'ushort') ;
if gt(slices, 1)
disp(['- multislices data; ', num2str(slices), ' slices']);
else
disp('- single slice data');
end
% Read spectral table data
l = fread(fidOCT, 1, 'long'); % Length of spectral table data
ST = fread(fidOCT, l, 'long'); % Spectral table data
% Read resample table data
l = fread(fidOCT, 1, 'long'); % Length of resample table data
RT = fread(fidOCT, l, 'float'); % Resample data
% Read stray light data (4 channels)
l = fread(fidOCT, 1, 'long'); % Length of stray light channel 1
ch(:,1) = fread(fidOCT, l, 'short'); % Stray light channel 1 data
SL = ch(:,channel);
clear ch
% Read noise floor data (4 channels)
l = fread(fidOCT, 1, 'long'); % Length of noise floor channel 1
ch(:,1) = fread(fidOCT, l, 'float'); % Noise floor channel 1 data
NF = ch(:,channel);
clear ch
% Read data frame
c = fread(fidOCT, 1, 'long'); % no. of columns of raw data 2D array
% (# of acquired A-scans = # of A-scans per tomography * avgfac)
r = fread(fidOCT, 1, 'long'); % no. of rows of raw data 2D array (# of samples per A-scan)
RD0 = fread(fidOCT, [r c], 'short'); % raw data
for jj = 1:slices
if gt(slices,1);
disp(['- Computing slice no. ', num2str(jj)]);
end
RD = RD0(:,(jj-1) * c/slices +1 : jj * c/slices );
% Rescale and resample the raw data from the selected input channel (channel)
% perform steps 1-5 as from MD documentation
% NOTE: the function is defined in this script
RD = F MDFresample(SL, ST, RT, RD, jj);
% Compute the (inverse) fft to transform the raw data signal from f-space (frequancy domain) into time domain
disp('- Computing the DFT...');
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E = fft(RD); % 6. d
clear RD ans
xs = c/avgfac/slices;
zs = r;
% Taking first half of the data
E = E(1:r/2, :);
% Structural image, i.e. REFLECTIVITY image,
% expressed in dB, NB: [log10] not [log] used
S = 10 * log10( abs(E).ˆ2 );
%%%%%%%%%%%%%%%%%%%%%%%%%%PHASE%%%%%%%%%%%%%%%%%%%%%%%%
xaxis=(1:size(E,2))*(expo)/size(E,2);
%find surface
[val,surface]=max(S(:,500));
yaxis=(1:size(E,1));
yaxis=yaxis-surface;
yaxis=yaxis*2.5e-3;
h=imagesc(xaxis,yaxis,S);colormap gray
xlabel('$$Time /\mu s$$','Interpreter','latex');
ylabel('$$Depth/mm$$','Interpreter','latex');
title('$$\textit{M mode scan of Gelatine/Milk Phantom}$$','Interpreter','latex')
set(findall(gcf,'type','text'),'fontSize',16,'Interpreter','latex');
axis([0 inf -0.09 1])
line=repmat(20e3,[0 1000]);
hold on; plot(xaxis,20e-3,'g-');
% print -depsc Gelatinphantom.eps
% [x,posn]=ginput(1)
posn=20e-3; %distance below surface 20microns
%PHASE%%%%%%%%%%%
phase=(angle(E));
Phase=phase(:,1:1000);
%index value posn=pix below+surface position
posn2=(posn/2.5e-3)+surface;
standdev=std(Phase(posn2,1:999))
P=figure(); plot(xaxis,Phase(posn2,:))
xlabel('$$Time /\mu s$$','Interpreter','latex');
ylabel('$$Phase /rad$$','Interpreter','latex');
title('$$\textit{Phase Fluctuation of Gelatine/Milk Phantom}$$','Interpreter','latex')
set(findall(gcf,'type','text'),'fontSize',16,'Interpreter','latex');
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axis([-inf 50.5 -inf inf])
print -depsc highPhase.eps
%FFT of phase measurement -to find freq of oscillation&&&7
FFT phase=(abs(fft(Phase(posn2,:)))).ˆ2;
s=size(FFT phase,2)+1;
FFT phase1=(FFT phase(1:s/2)); %select only positive frequency
FFT len=length(FFT phase1);
xax= (1:FFT len)/(FFT len)*(0.5*1e3/expo);
FF=figure(); plot(xax,((FFT phase1)));
clear s; s=max(FFT phase1(8:end));
axis([0 2 -inf inf])
xlabel('$$Frequency /kHz$$','Interpreter','latex');
ylabel('$$\textit{Phase sq} /radˆ\textit{2}$$','Interpreter','latex');
title('$$\textit{FFT of Phase Fluctuation}$$','Interpreter','latex')
set(findall(gcf,'type','text'),'fontSize',16,'Interpreter','latex');
print -depsc highFFT Phase.eps
print -depsc FFT Phase.eps
end
end
6.3 MATLAB Script for MMOCT processing
% Process OCT file and produce Structural image data set S
%
% SNR improvement / smooth the image
S = F SNRimprovement(S,de,wi,treshold);
figure;imagesc(S);
title(['Structural Image', num2str(jj)]);
xlabel('Width (\itmm\rm)');
ylabel('Depth (\itmm\rm)');
colormap gray;
% imwrite(S,'Structural.png');
print('-dpng','-r72','Structure.png')
%Find Phase
angleE=angle(E);
%length of signal
len=size(angleE,2);
xx=linspace(1,(Acq/2),(len/2));
% %Unwrap 2pi
unwrapD=unwrap(angleE,[],2);
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%max displacement
displacement= unwrapD.*((890e-9)/(4*pi*1.3));
maxDisp=max(max(displacement))
%differentiate to remove time independent phase
diffAngle=diff(unwrapD,1,2);
displacement= diffAngle.*((890e-9)/(4*pi*1.3));
maxDisp2=max(max(displacement))
%fft of unwrap phase this shows the freqs in phase
% NFFT=2ˆnextpow2(size(diffAngle));%fft length
aFFT=((fft(diffAngle')));
% meanaFFT=mean(aFFT,2);
aFFT=aFFT(1:len/2,:);
figure;plot(xx,(abs(aFFT)).ˆ2); title('Absolute FFT of unwrapped Phase');
xlabel('Frequency/Hz');
aFFTnoise=mean(mean(abs(aFFT(2000:end,:)).ˆ2));
[b cut a cut]=butter(5,[0.29 0.35],'bandpass'); %160Hz
H=freqz(b cut,a cut,(len/2)); % freq response of filter
figure; plot(xx,abs(H))% see filter frequency response
title('Filter Freq Response');xlabel('Frequency/ Hz');
print('-dpng','-r72','Filter.png')
for nn=1:size(unwrapD,1);
phase filtered(nn,:)=filter(b cut,a cut,diffAngle(nn,:));
end
figure; imagesc(phase filtered);
title('Filter Phase Image');
yy=abs(fft(phase filtered')).ˆ2;
figure; plot(xx,(yy(1:(len/2),:))); title('Filtered absolute FFT of unwrapped phase');
xlabel('Frequency/Hz');
clear yy
print('-dpng','-r72','FilterdabsoluteFFT.png')
%%%SLIDING WINDOW
win width = 100; %Sliding window width
slide incr = win width; %Slide for each iteration
%windowing function
win = hamming((win width +1), 'periodic');
%repeat window to fit all of data matrix
win=repmat(win,[1 size(phase filtered,1)]);
%place window matrix onto GPU
%win=gpuArray(win);
nfft=(2ˆnextpow2(win width));%fft length
X=(phase filtered); %place data on gpu
stft=zeros(size(phase filtered,1),len-win width-1); %preallocate final matrix on gpu
% stft=gpuArray.zeros([800 50]);
% X=gpuArray(diffAngle);
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%windowing
h=waitbar(0,'wait...');
for ii = 1:(len-win width-1);
waitbar(ii/(len-win width-1),h,sprintf('%d',ii))
% mean win(ii) = mean(a(ii:ii+win width));%Calculation for each window
% X=gpuArray(phase filtered(nn,ii:ii+win width));
Xi=X(:,ii:ii+win width);
Xi=Xi.*win';
temp=(abs(fft(Xi,nfft,2))).ˆ2;
stft(:,ii)=((temp(:,22)));%160
end
close(h);
STFT=gather(stft);
figure;imagesc(STFT);
colormap jet
colorbar
print('-dpng','-r72','STFT.png')
end
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